https://www.hawaiihealthdigest.com/article/907162998-nipsapp-game-studios-announces-ai-driven-vr-solutions-for-surgical-training-and-nuclear-safety Hawaii Health Digest en PressRelease 2026-04-21T16:24:00+00:00 NipsApp Game Studios Announces AI-Driven VR Solutions for Surgical Training and Nuclear Safety https://pressranger.s3.us-west-1.amazonaws.com/3234700/The-Hindu.jpg https://www.hawaiihealthdigest.com/article/907163482-bronson-methodist-hospital-named-no-1-academic-medical-center-in-the-nation-earns-premier-100-top-hospital-honor Hawaii Health Digest en PressRelease 2026-04-21T16:22:31+00:00 Bronson Methodist Hospital Named No. 1 Academic Medical Center in the Nation; Earns Premier 100 Top Hospital® Honor https://ml.globenewswire.com/media/e43d0be7-916a-4886-81e2-27ca4942b827/medium/bronson-methodist-hospital-in-kalamazoo-mich.JPG https://www.hawaiihealthdigest.com/article/907162698-avacta-data-at-aacr-2026-underline-favorable-profile-of-ava6103-and-advantages-of-pre-cision-delivery-platform Hawaii Health Digest en PressRelease 2026-04-21T16:00:00+00:00 Avacta data at AACR 2026 underline favorable profile of AVA6103 and advantages of pre|CISION® delivery platform https://ml.globenewswire.com/media/63584766-21c6-42e8-944c-7103432b045b/small/avacta-logo-full-color-rgb-oct-2024-jpg.jpg https://www.hawaiihealthdigest.com/article/907162851-intermountain-health-primary-children-s-hospital-in-lehi-utah-is-already-expanding Hawaii Health Digest en PressRelease 2026-04-21T15:37:45+00:00 Intermountain Health Primary Children’s Hospital in Lehi, Utah is Already Expanding https://ml.globenewswire.com/media/YTRjYjVlNmQtZmVmYy00NDhmLTgyZDUtZTlmNzk0NmJhOWY3LTEyNjkxMjYtMjAyNi0wNC0yMS1lbg==/tiny/Intermountain-Health.png https://www.hawaiihealthdigest.com/article/907153789-revolution-medicines-to-present-pivotal-phase-3-rasolute-302-clinical-trial-results-for-daraxonrasib-in-previously-treated-metastatic-pancreatic Hawaii Health Digest en PressRelease 2026-04-21T15:23:01+00:00 Revolution Medicines to Present Pivotal Phase 3 RASolute 302 Clinical Trial Results for Daraxonrasib in Previously Treated Metastatic Pancreatic Cancer During a Plenary Session at the 2026 ASCO Annual Meeting https://ml.globenewswire.com/media/771b34d9-586d-435a-a976-ab0ab847571b/small/balanced-green-primary-logo-medium-1000px-png.png https://www.hawaiihealthdigest.com/article/907153350-becoming-independent-named-no-17-on-the-nonprofit-times-2026-best-nonprofits-to-work-for Hawaii Health Digest en PressRelease 2026-04-21T15:15:00+00:00 Becoming Independent Named No. 17 on “The NonProfit Times' 2026 Best Nonprofits To Work For” https://ml.globenewswire.com/media/58d05702-9c01-4ca3-9d17-7d25146c5587/small/bi-logo-pack-green-cmyk-249kb-jpg.jpg https://www.hawaiihealthdigest.com/article/907153044-record-breaking-springfest-2026-affirms-a4m-as-the-central-forum-for-longevity-medicine Hawaii Health Digest en PressRelease 2026-04-21T15:00:00+00:00 Record-Breaking SpringFest 2026 Affirms A4M as the Central Forum for Longevity Medicine https://ml.globenewswire.com/media/OWM2NDdhZTQtNzY2Ny00Y2MzLWFmY2ItYmIzODMxNTJjOTNlLTUwMDEyODY4NS0yMDI2LTA0LTIxLWVu/tiny/American-Academy-of-Anti-Aging.png https://www.hawaiihealthdigest.com/article/907153774-remix-therapeutics-announces-oral-presentation-of-first-in-class-small-molecule-myb-mrna-degrader-rem-422-phase-1-2-aria-trial-results-at-the-2026 Hawaii Health Digest en PressRelease 2026-04-21T15:00:00+00:00 Remix Therapeutics Announces Oral Presentation of First-in-Class Small Molecule MYB mRNA Degrader REM-422 Phase 1/2 ARIA Trial Results at the 2026 American Society of Clinical Oncology Annual Meeting https://ml.globenewswire.com/media/4facea87-f600-4440-a295-a31bb083c9bd/small/remix-logo-png.png https://www.hawaiihealthdigest.com/article/907152791-xeltis-releases-groundbreaking-new-12-month-eu-pivotal-data-for-axess-demonstrating-the-transformative-potential-in-hemodialysis-treatment Hawaii Health Digest en PressRelease 2026-04-21T14:50:00+00:00 Xeltis releases groundbreaking new 12-month EU pivotal data for aXess™ demonstrating the transformative potential in hemodialysis treatment https://ml-eu.globenewswire.com/media/dee0d6ab-8850-4503-bdcd-ede435e96729/small/xeltis-youtube-logo-high-res-002-png.png https://www.hawaiihealthdigest.com/article/907152903-trethera-announces-appointment-of-m-andrew-drew-woodmansee-to-board-of-directors Hawaii Health Digest en PressRelease 2026-04-21T14:42:00+00:00 Trethera Announces Appointment of M. Andrew (“Drew”) Woodmansee to Board of Directors https://ml.globenewswire.com/media/2a7ea251-6a26-4ee9-97cf-a9dda8ccba1d/small/picture1-jpg.jpg https://www.hawaiihealthdigest.com/article/907153754-black-diamond-therapeutics-announces-oral-presentation-of-silevertinib-phase-2-data-in-frontline-egfrm-nsclc-patients-at-the-2026-asco-annual-meeting Hawaii Health Digest en PressRelease 2026-04-21T14:40:00+00:00 Black Diamond Therapeutics Announces Oral Presentation of Silevertinib Phase 2 Data in Frontline EGFRm NSCLC Patients at the 2026 ASCO Annual Meeting https://ml.globenewswire.com/media/b8da4d92-789b-4f0a-a1e2-2739af370155/small/bdtxlogo-pantone3135c-png-png.png https://www.hawaiihealthdigest.com/article/907152854-itm-to-announce-quality-of-life-data-from-the-phase-3-compete-trial-in-patients-with-gastroenteropancreatic-neuroendocrine-tumors-gep-nets-at-asco Hawaii Health Digest en PressRelease 2026-04-21T14:30:22+00:00 ITM to Announce Quality of Life Data from the Phase 3 COMPETE Trial in Patients with Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) at ASCO 2026 https://ml-eu.globenewswire.com/media/3411c2bd-01a5-4d06-ad90-4a6e168bad61/small/itm-logo-claim-rgb-high-res-png.png https://www.hawaiihealthdigest.com/article/907152828-glp-diet-app-launches-personalized-wellness-app-for-glp-1-medication-users-earns-2-500-app-reviews Hawaii Health Digest en PressRelease 2026-04-21T14:30:00+00:00 GLP Diet App Launches Personalized Wellness App for GLP-1 Medication Users, Earns 2,500+ App Reviews https://ml-eu.globenewswire.com/media/14da2855-c153-4f17-98b5-0b26ef17f7be/medium/glp-diet-is-gaining-popularity.png https://www.hawaiihealthdigest.com/article/907153563-global-virus-network-on-measles-resurgence Hawaii Health Digest en PressRelease 2026-04-21T14:30:00+00:00 Global Virus Network on Measles Resurgence https://ml.globenewswire.com/media/6c1b2724-7b9b-469a-a7c3-bc0a64d716ae/small/gvn-lt-gr-gradiant-jpg.jpg https://www.hawaiihealthdigest.com/article/907153590-cemdisiran-dosed-subcutaneously-every-12-weeks-demonstrates-rapid-deep-and-sustained-disease-control-in-generalized-myasthenia-gravis-gmg-phase-3 Hawaii Health Digest en PressRelease 2026-04-21T14:30:00+00:00 Cemdisiran, Dosed Subcutaneously Every 12 Weeks, Demonstrates Rapid, Deep and Sustained Disease Control in Generalized Myasthenia Gravis (gMG) Phase 3 Trial https://ml.globenewswire.com/media/add5ebc7-88c9-49dc-8834-abbb07c622d1/small/regeneron-logo-jpg.jpg https://www.hawaiihealthdigest.com/article/907153661-zentalis-pharmaceuticals-announces-abstract-acceptance-at-asco-2026-featuring-azenosertib-in-combination-with-paclitaxel-for-platinum-resistant Hawaii Health Digest en PressRelease 2026-04-21T14:27:05+00:00 Zentalis Pharmaceuticals Announces Abstract Acceptance at ASCO 2026 Featuring Azenosertib in Combination with Paclitaxel for Platinum-Resistant Ovarian Cancer https://ml.globenewswire.com/media/1b481d6d-51c9-44f0-b33f-81feb1061d2e/small/zentalis-logo-png.png https://www.hawaiihealthdigest.com/article/907152848-immatics-announces-four-upcoming-oral-presentations-across-its-clinical-cell-therapy-and-bispecific-portfolio-at-2026-asco-annual-meeting Hawaii Health Digest en PressRelease 2026-04-21T14:25:55+00:00 Immatics Announces Four Upcoming Oral Presentations Across Its Clinical Cell Therapy and Bispecific Portfolio at 2026 ASCO Annual Meeting https://ml-eu.globenewswire.com/media/1ef1cd0c-384c-4889-82c8-58bd42054fb8/small/immatics-final-logo-r-white-background-png.png https://www.hawaiihealthdigest.com/article/907144469-nextcure-and-simcere-s-sim0505-cdh6-adc-phase-1-data-to-be-presented-at-asco-2026 Hawaii Health Digest en PressRelease 2026-04-21T14:15:00+00:00 NextCure and Simcere’s SIM0505 (CDH6 ADC) Phase 1 Data to be Presented at ASCO 2026 https://ml.globenewswire.com/media/df24cd65-0f3d-4ede-9e7a-c3f58ce6e9d4/small/logo-nextcure-jpg.jpg https://www.hawaiihealthdigest.com/article/907145392-aprea-therapeutics-to-provide-clinical-update-on-acesot-1051-phase-1-trial-evaluating-wee1-inhibitor-apr-1051-at-asco-2026-annual-meeting Hawaii Health Digest en PressRelease 2026-04-21T14:15:00+00:00 Aprea Therapeutics to Provide Clinical Update on ACESOT-1051 Phase 1 Trial Evaluating WEE1 Inhibitor, APR-1051, at ASCO 2026 Annual Meeting https://ml.globenewswire.com/media/c63a19fa-f624-43d3-852f-d5956983aef3/small/aprea-logo-jpg.jpg https://www.hawaiihealthdigest.com/article/907144128-4bio-capital-portfolio-company-ray-therapeutics-announces-upsized-and-oversubscribed-125-million-series-b-financing-for-vision-restoration-treatments Hawaii Health Digest en PressRelease 2026-04-21T14:13:17+00:00 4BIO Capital portfolio company Ray Therapeutics announces upsized and oversubscribed $125 Million Series B financing for vision restoration treatments https://ml-eu.globenewswire.com/media/fab6412c-5edc-4903-8a71-51e5ccc6accb/small/4bio-capital-logo-png.png https://www.hawaiihealthdigest.com/article/907144122-impact-biotech-announces-upcoming-data-presentations-for-padeliporfin-vtp-at-aua-and-asco-2026 Hawaii Health Digest en PressRelease 2026-04-21T14:00:00+00:00 ImPact Biotech Announces Upcoming Data Presentations for Padeliporfin VTP at AUA and ASCO 2026 https://ml-eu.globenewswire.com/media/68762066-1fff-4065-af45-d18da25273cd/small/impact-biotech-logo-final-resized-jpg.jpg https://www.hawaiihealthdigest.com/article/907144129-concerned-about-supporting-erectile-health-life-extension-launches-new-men-s-sexual-health-supplement Hawaii Health Digest en PressRelease 2026-04-21T14:00:00+00:00 Concerned About Supporting Erectile Health? Life Extension Launches New Men’s Sexual Health Supplement https://ml.globenewswire.com/media/MGZmYTU5YWUtNGU0Ny00YWNhLWJjZDktNjc2NTBhMThjNzcwLTEyMDU5MDYtMjAyNi0wNC0yMS1lbg==/tiny/Life-Extension.png https://www.hawaiihealthdigest.com/article/907144137-dewpoint-therapeutics-reports-preclinical-data-on-oral-myc-condensate-modulator-at-aacr-2026 Hawaii Health Digest en PressRelease 2026-04-21T14:00:00+00:00 Dewpoint Therapeutics Reports Preclinical Data on Oral MYC Condensate Modulator at AACR 2026 https://ml.globenewswire.com/media/e6f24195-bede-49a6-a925-b7dceea78e57/small/dewpoint-logo-centered-full-color-png.png https://www.hawaiihealthdigest.com/article/907144152-cardiff-oncology-to-present-updated-phase-2-data-of-onvansertib-in-first-line-ras-mutated-mcrc-in-a-rapid-oral-session-at-asco-2026 Hawaii Health Digest en PressRelease 2026-04-21T14:00:00+00:00 Cardiff Oncology to Present Updated Phase 2 Data of Onvansertib in First-Line RAS-Mutated mCRC in a Rapid Oral Session at ASCO 2026 https://ml.globenewswire.com/media/916adb81-8173-4fbe-8095-c284c4f44cd3/small/cardiff-jpg.jpg https://www.hawaiihealthdigest.com/article/907144160-disc-medicine-announces-oral-presentation-of-data-from-rally-mf-phase-2-trial-of-disc-0974-in-patients-with-myelofibrosis-and-anemia-at-the-american Hawaii Health Digest en PressRelease 2026-04-21T14:00:00+00:00 Disc Medicine Announces Oral Presentation of Data from RALLY-MF Phase 2 Trial of DISC-0974 in Patients with Myelofibrosis and Anemia at the American Society of Clinical Oncology (ASCO) Annual Meeting https://ml.globenewswire.com/media/d212c899-9a87-4500-9382-573dfe9f12af/small/disc-logo-horiz-fullcolor-rgb-jpg.jpg https://www.hawaiihealthdigest.com/article/907144227-cellectar-biosciences-announces-subset-of-clover-wam-clinical-trial-data-accepted-for-presentation-at-the-american-society-of-clinical-oncology Hawaii Health Digest en PressRelease 2026-04-21T14:00:00+00:00 Cellectar Biosciences Announces Subset of CLOVER WaM Clinical Trial Data Accepted for Presentation at the American Society of Clinical Oncology Conference 2026 https://ml.globenewswire.com/media/980abc5d-826f-4ac3-ad81-f07d69b34af6/small/cellectar-logo-1-jpg.jpg https://www.hawaiihealthdigest.com/article/907144231-actg-launches-critical-study-evaluating-hormone-therapy-for-women-living-with-hiv-in-the-menopause-transition Hawaii Health Digest en PressRelease 2026-04-21T14:00:00+00:00 ACTG Launches Critical Study Evaluating Hormone Therapy for Women Living with HIV in the Menopause Transition https://ml.globenewswire.com/media/1e94313a-1d33-49e8-bd5e-fd0c911661c9/small/image1-png.png https://www.hawaiihealthdigest.com/article/907145205-leads-biolabs-pd-l1-4-1bb-bispecific-antibody-opamtistomig-lbl-024-enters-phase-trial-with-first-patient-dosing-in-gastric-cancer-pioneering Hawaii Health Digest en PressRelease 2026-04-21T13:47:09+00:00 Leads Biolabs' PD-L1/4-1BB Bispecific Antibody Opamtistomig (LBL-024) Enters Phase Ⅱ Trial with First Patient Dosing in Gastric Cancer, Pioneering Enhanced Immunotherapy Combination Strategies https://ml.globenewswire.com/media/MGZhMTI3YWEtMDgwZS00ZGVlLTg5MzItYjQxOWI5ODY4Mjc3LTEzMDgzODktMjAyNi0wNC0yMS1lbg==/tiny/LEADS-BIOLABS-CO-LTD-.png https://www.hawaiihealthdigest.com/article/907144731-lachine-hospital-foundation-gala-raises-322-115-to-transform-health-care-in-the-west-island Hawaii Health Digest en PressRelease 2026-04-21T13:31:17+00:00 Lachine Hospital Foundation Gala raises $322,115 to transform health care in the West Island https://ml.globenewswire.com/media/12f4e9fa-5811-4a1a-a134-b657bc1e4000/medium/lachine-hospital-foundation-gala-raises-322-115-to-transform.jpg https://www.hawaiihealthdigest.com/article/907144804-le-gala-de-la-fondation-de-l-h-pital-de-lachine-recueille-322-115-pour-transformer-les-soins-de-sant-dans-l-ouest-de-l-le Hawaii Health Digest en PressRelease 2026-04-21T13:31:17+00:00 Le Gala de la Fondation de l’Hôpital de Lachine recueille 322 115 $ pour transformer les soins de santé dans l’Ouest-de-l’Île https://ml.globenewswire.com/media/12f4e9fa-5811-4a1a-a134-b657bc1e4000/medium/le-gala-de-la-fondation-de-lhopital-de-lachine-recueille-322.jpg https://www.hawaiihealthdigest.com/article/907144126-focus-on-french-healthtech-s-ecosystem-panorama-france-healthtech-2026-s-review-a-mature-innovative-and-resilient-sector-facing-a-more-demanding Hawaii Health Digest en PressRelease 2026-04-21T13:30:00+00:00 Focus on French HealthTech’s ecosystem : Panorama France HealthTech 2026 ‘s review: a mature, innovative and resilient sector facing a more demanding environment https://ml-eu.globenewswire.com/media/NDZkYjRhMmYtYzk2Ny00YTE0LTkxNzgtMDkyYTIzM2ZkMTgyLTEyNjc2MjAtMjAyNi0wNC0yMS1lbg==/tiny/FP2COM.png https://www.hawaiihealthdigest.com/article/907144221-qhslab-otcqb-usaq-reports-127-year-over-year-isp-growth-and-launches-q-connect-glp-1-support-assessment Hawaii Health Digest en PressRelease 2026-04-21T13:15:00+00:00 QHSLab (OTCQB:USAQ) Reports 127% Year-Over-Year ISP Growth and Launches Q-Connect GLP-1 Support Assessment  https://ml.globenewswire.com/media/52b3dc5d-608c-487d-8b43-a4dfa1155e15/small/logo-png.png https://www.hawaiihealthdigest.com/article/907144625-eclipse-energy-and-wood-to-scale-hydrogen-production-from-end-of-life-oil-fields Hawaii Health Digest en PressRelease 2026-04-21T13:15:00+00:00 Eclipse Energy and Wood to Scale Hydrogen Production from End-of-Life Oil Fields https://ml.globenewswire.com/media/ffa0146b-9ebf-479c-865b-d6e55e0e9adc/small/eclipse-hero-vertical-blk-lg-png.png https://www.hawaiihealthdigest.com/article/907136324-outlook-therapeutics-completes-federal-dispute-resolution-fdr-meeting-with-fda-for-ons-5010-lytenava-bevacizumab-vikg Hawaii Health Digest en PressRelease 2026-04-21T13:05:00+00:00 Outlook Therapeutics Completes Federal Dispute Resolution (FDR) Meeting with FDA for ONS-5010/LYTENAVA™ (bevacizumab-vikg) https://ml.globenewswire.com/media/cbff3302-f8d2-466a-beff-8c33252f9c70/small/otlk-png.png https://www.hawaiihealthdigest.com/article/907136334-pacbio-and-lucid-genomics-announce-compatibility-collaboration-to-advance-tertiary-analysis-for-long-read-sequencing Hawaii Health Digest en PressRelease 2026-04-21T13:05:00+00:00 PacBio and Lucid Genomics Announce Compatibility Collaboration to Advance Tertiary Analysis for Long-Read Sequencing https://ml.globenewswire.com/media/f408d681-e68c-4113-a7cd-be24486deefc/small/logo-centered-440x386-png.png https://www.hawaiihealthdigest.com/article/907135218-stereotaxis-to-report-first-quarter-2026-financial-results-on-may-12-2026 Hawaii Health Digest en PressRelease 2026-04-21T13:01:00+00:00 Stereotaxis to Report First Quarter 2026 Financial Results on May 12, 2026 https://ml.globenewswire.com/media/95a5b8ca-b7c0-4c80-8ca7-063ef10706c3/small/stereotaxis-logo-new-tagline-black-text-png.png https://www.hawaiihealthdigest.com/article/907134970-world-s-fastest-hiv-test-added-to-the-together-takemehome-program-for-free-at-home-hiv-self-testing-across-the-united-states Hawaii Health Digest en PressRelease 2026-04-21T13:00:00+00:00 World’s Fastest HIV Test added to the Together TakeMeHome Program for Free at Home HIV Self-Testing Across the United States https://ml.globenewswire.com/media/75685099-6350-45fb-b96d-e7dea96bbf55/medium/at-home-hiv-testing-made-simple.jpg https://www.hawaiihealthdigest.com/article/907135193-new-bay-area-lyme-foundation-study-shows-common-fda-cleared-lyme-tests-miss-64-78-of-early-cases-underscores-urgent-need-for-improved-diagnostics Hawaii Health Digest en PressRelease 2026-04-21T13:00:00+00:00 New Bay Area Lyme Foundation Study Shows Common FDA-Cleared Lyme Tests Miss 64-78% of Early Cases, Underscores Urgent Need for Improved Diagnostics https://ml.globenewswire.com/media/388871d3-1a1a-48cf-8ebf-c08773485acd/small/bay-area-logo-0425-png.png https://www.hawaiihealthdigest.com/article/907135221-aux-labs-secures-4m-to-commercialize-precision-fermentation-cheese-platform Hawaii Health Digest en PressRelease 2026-04-21T13:00:00+00:00 AuX Labs Secures $4M to Commercialize Precision Fermentation Cheese Platform https://ml.globenewswire.com/media/8c024de8-d111-4d2f-8a46-7a0cec7f980c/medium/aux-labs-mozzarella.jpg https://www.hawaiihealthdigest.com/article/907135605-lice-clinics-of-america-longmont-hosts-annual-easter-egg-hunt-with-free-lice-checks-treatments Hawaii Health Digest en PressRelease 2026-04-21T13:00:00+00:00 Lice Clinics of America – Longmont Hosts Annual Easter “Egg Hunt” with Free Lice Checks & Treatments https://ml.globenewswire.com/media/OTQ4ZjJlMDktMWNjMC00MTc1LWE3MTYtMmQxNTI4MTVmYTM4LTEyNzQ4MjQtMjAyNi0wNC0yMS1lbg==/tiny/Lice-Clinics-of-America.png https://www.hawaiihealthdigest.com/article/907135833-akari-therapeutics-asco-abstract-acceptance-highlights-potential-for-aktx-101-adc-to-treat-kras-mutant-tumors Hawaii Health Digest en PressRelease 2026-04-21T13:00:00+00:00 Akari Therapeutics ASCO Abstract Acceptance Highlights Potential for AKTX-101 ADC to Treat KRAS Mutant Tumors https://ml.globenewswire.com/media/8d978f50-07a9-40a3-be69-45f51ccd94d9/small/akari-logo-1-jpg.jpg https://www.hawaiihealthdigest.com/article/907136206-twentyeight-health-launches-first-nationwide-all-in-one-virtual-clinic-personalized-care-for-women Hawaii Health Digest en PressRelease 2026-04-21T13:00:00+00:00 Twentyeight Health Launches First Nationwide All-in-One Virtual Clinic & Personalized Care for Women https://ml.globenewswire.com/media/ab364761-0cc6-4c5e-9483-815a4f74e08a/small/twentyeight-health-logo-jpg.jpg https://www.hawaiihealthdigest.com/article/907136441-brain-cancer-canada-marks-brain-cancer-awareness-month-in-may-with-national-landmark-lightings-community-events-new-research-investments-and-a-call Hawaii Health Digest en PressRelease 2026-04-21T13:00:00+00:00 Brain Cancer Canada Marks Brain Cancer Awareness Month in May with National Landmark Lightings, Community Events, New Research Investments, and a Call to Action https://ml.globenewswire.com/media/78a73b7f-a470-42a5-9976-aa425939a68b/small/bcc-logo-2024-png.png https://www.hawaiihealthdigest.com/article/907137563-nexgel-new-strategic-partner-sequence-lifescience-leads-financing-with-5-5-million-to-complete-acquisition-of-celularity-degenerative-disease Hawaii Health Digest en PressRelease 2026-04-21T13:00:00+00:00 NEXGEL New Strategic Partner, Sequence LifeScience™, Leads Financing with $5.5 Million to Complete Acquisition of Celularity Degenerative Disease Segment https://ml.globenewswire.com/media/0e76fff8-7aee-4b60-ba26-62dda9975939/small/logo-png.png https://www.hawaiihealthdigest.com/article/907137450-fortrea-announces-date-for-first-quarter-2026-financial-results-and-conference-call Hawaii Health Digest en PressRelease 2026-04-21T12:45:00+00:00 Fortrea Announces Date for First Quarter 2026 Financial Results and Conference Call https://ml.globenewswire.com/media/9fbbe00b-8782-464e-83e6-5843c563884a/small/fortrea-logo-jpg.jpg https://www.hawaiihealthdigest.com/article/907136452-moleculin-announces-abstract-accepted-for-poster-presentation-at-the-2026-asco-annual-meeting Hawaii Health Digest en PressRelease 2026-04-21T12:36:00+00:00 Moleculin Announces Abstract Accepted for Poster Presentation at the 2026 ASCO Annual Meeting https://ml.globenewswire.com/media/7fa09722-2ef8-49fc-bc24-6b150093f8ba/small/mbrx-logo-png.png https://www.hawaiihealthdigest.com/article/907135060-neuronetics-to-report-first-quarter-2026-financial-and-operating-results-and-host-conference-call Hawaii Health Digest en PressRelease 2026-04-21T12:30:00+00:00 Neuronetics to Report First Quarter 2026 Financial and Operating Results and Host Conference Call https://ml.globenewswire.com/media/12db9039-d4bf-41a0-8b4a-324398e392b4/small/neuronetics-logo-rgb-purple-png.png https://www.hawaiihealthdigest.com/article/907136327-oncotelic-therapeutics-inc-otcqb-otlc-leveraging-expertise-amid-evaluation-evolution Hawaii Health Digest en PressRelease 2026-04-21T12:30:00+00:00 Oncotelic Therapeutics Inc. (OTCQB: OTLC) Leveraging Expertise amid Evaluation Evolution https://ml.globenewswire.com/media/aa650511-a1c3-496e-803a-448d7f8d409a/small/picture1-jpg.jpg https://www.hawaiihealthdigest.com/article/907136328-journey-medical-corporation-secures-contract-with-third-major-gpo-for-emrosi Hawaii Health Digest en PressRelease 2026-04-21T12:30:00+00:00 Journey Medical Corporation Secures Contract with Third Major GPO for Emrosi™ https://ml.globenewswire.com/media/68f0b467-248f-4250-9cda-2c7a68a11a1d/small/journeylogo-1-jpg.jpg https://www.hawaiihealthdigest.com/article/907136365-milestone-scientific-inc-completes-2-15-million-private-placement Hawaii Health Digest en PressRelease 2026-04-21T12:30:00+00:00 Milestone Scientific Inc. Completes $2.15 Million Private Placement https://ml.globenewswire.com/media/408ad3c5-6ad3-41bd-9763-356666216796/small/milestonelogo-rgb-final-jpg.jpg https://www.hawaiihealthdigest.com/article/907136403-allogene-therapeutics-expands-pivotal-phase-2-alpha3-trial-to-south-korea-and-australia Hawaii Health Digest en PressRelease 2026-04-21T12:30:00+00:00 Allogene Therapeutics Expands Pivotal Phase 2 ALPHA3 Trial to South Korea and Australia https://ml.globenewswire.com/media/87e8712c-0741-409f-9942-c91b31e7c5e1/small/allogene-png.png https://www.hawaiihealthdigest.com/article/907136426-celularity-announces-closing-of-transaction-with-nexgel Hawaii Health Digest en PressRelease 2026-04-21T12:30:00+00:00 Celularity Announces Closing of Transaction with NexGel https://ml.globenewswire.com/media/ZDdlZDY3ZmYtNGQwNi00M2U2LWFiZGQtYjdkODg0YjNiMzFhLTEyMTY1NjItMjAyNi0wNC0yMS1lbg==/tiny/Celularity-Inc-.png https://www.hawaiihealthdigest.com/article/907136433-polaryx-therapeutics-receives-u-s-fda-fast-track-designations-for-all-four-indications-to-be-evaluated-in-the-soteria-basket-trial Hawaii Health Digest en PressRelease 2026-04-21T12:30:00+00:00 Polaryx Therapeutics Receives U.S. FDA Fast Track Designations for All Four Indications to be Evaluated in the SOTERIA Basket Trial https://ml.globenewswire.com/media/64e2f507-40e8-46aa-b22e-6661e7035467/small/polaryx-logonew-png.png https://www.hawaiihealthdigest.com/article/907136438-enlivex-announces-second-regulatory-approval-for-phase-2b-trial-of-allocetra-in-age-related-primary-moderate-to-severe-knee-osteoarthritis Hawaii Health Digest en PressRelease 2026-04-21T12:30:00+00:00 Enlivex Announces Second Regulatory Approval for Phase 2b Trial of Allocetra in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis https://ml.globenewswire.com/media/27d4e006-8709-4fd1-8341-5b58381487d4/small/picture1-jpg.jpg https://www.hawaiihealthdigest.com/article/907136846-cristcot-announces-fda-acceptance-of-nda-for-next-generation-hydrocortisone-acetate-nghca-for-treatment-of-ulcerative-colitis-uc-of-the-rectum Hawaii Health Digest en PressRelease 2026-04-21T12:30:00+00:00 Cristcot Announces FDA Acceptance of NDA for Next-Generation Hydrocortisone Acetate (ngHCA) for Treatment of Ulcerative Colitis (UC) of the Rectum https://ml.globenewswire.com/media/ZjcwNjEwOGEtZWEwZi00MTJkLWEzODgtYTFjYTIzYTlhMWI1LTEzMjI0MTAtMjAyNi0wNC0yMS1lbg==/tiny/Cristcot-HD-LLC.png https://www.hawaiihealthdigest.com/article/907136773-bioaegis-therapeutics-announces-collaboration-with-prenosis-to-advance-ai-driven-precision-medicine-in-inflammatory-disease Hawaii Health Digest en PressRelease 2026-04-21T12:19:30+00:00 BioAegis Therapeutics Announces Collaboration with Prenosis to Advance AI-Driven Precision Medicine in Inflammatory Disease https://ml.globenewswire.com/media/0f901467-27cb-4506-a92d-a4f910b78919/small/bioaegis-therapeutics-logo-2-5-x-5-150-pixel-jpg.jpg https://www.hawaiihealthdigest.com/article/907126427-new-data-for-smith-nephew-s-cartiheal-agili-c-cartilage-repair-implant-demonstrates-superior-pain-relief-and-functional-gains-at-5-years Hawaii Health Digest en PressRelease 2026-04-21T12:00:00+00:00 New data for Smith+Nephew’s CARTIHEAL◊ AGILI-C◊ Cartilage Repair Implant demonstrates superior pain relief and functional gains at 5-years https://ml-eu.globenewswire.com/media/8512c693-36e3-49c5-9341-0e33875d614d/small/s-n-logo-jpg.jpg https://www.hawaiihealthdigest.com/article/907126485-innovage-to-announce-fiscal-third-quarter-2026-financial-results-and-host-conference-call-tuesday-may-5-2026 Hawaii Health Digest en PressRelease 2026-04-21T12:00:00+00:00 InnovAge to Announce Fiscal Third Quarter 2026 Financial Results and Host Conference Call Tuesday, May 5, 2026 https://ml.globenewswire.com/media/a1b976fe-053f-43be-b43c-532393a7f314/small/inn-logotag-rgb-jpg.jpg https://www.hawaiihealthdigest.com/article/907126536-allarity-therapeutics-presents-two-aacr-2026-posters-highlighting-stenoparib-s-potential-in-colorectal-cancer-as-well-as-new-predictive-data-linking Hawaii Health Digest en PressRelease 2026-04-21T12:00:00+00:00 Allarity Therapeutics Presents Two AACR 2026 Posters Highlighting Stenoparib’s Potential in Colorectal Cancer as well as New Predictive Data Linking DRP® and Overall Survival in Ovarian Cancer https://ml-eu.globenewswire.com/media/fd1e4c64-f0cf-40e0-a0c9-0be0d6dce544/small/allarity-full-color-rgb-2023jun07-png.png https://www.hawaiihealthdigest.com/article/907126549-catheter-precision-secures-u-s-patent-allowance-on-foundational-surgical-technology-establishing-powerful-ip-and-accelerating-scalable-growth Hawaii Health Digest en PressRelease 2026-04-21T12:00:00+00:00 Catheter Precision Secures U.S. Patent Allowance on Foundational Surgical Technology, Establishing Powerful IP and Accelerating Scalable Growth Strategy https://ml.globenewswire.com/media/cb9f10dc-be78-4c7c-a235-81bfdd77f03c/small/catheterlogo-jpg.jpg https://www.hawaiihealthdigest.com/article/907126551-spur-therapeutics-to-present-new-clinical-data-on-flt201-for-gaucher-disease-during-the-iwggd-2026-symposium Hawaii Health Digest en PressRelease 2026-04-21T12:00:00+00:00 Spur Therapeutics To Present New Clinical Data on FLT201 for Gaucher Disease during the IWGGD 2026 Symposium https://ml.globenewswire.com/media/195ccecc-f977-4fb5-ba01-43af7ec47589/small/spur-therapeutics-black-wopacity-rgb-png.png https://www.hawaiihealthdigest.com/article/907126628-krystal-biotech-to-report-first-quarter-2026-financial-results-on-may-4-2026 Hawaii Health Digest en PressRelease 2026-04-21T12:00:00+00:00 Krystal Biotech to Report First Quarter 2026 Financial Results on May 4, 2026 https://ml.globenewswire.com/media/94ec1f39-c0eb-4e65-9d7e-250519ef03f4/small/krys-logo-nobackground-with-registered-symbol-png.png https://www.hawaiihealthdigest.com/article/907126797-glucotrack-announces-publication-of-peer-reviewed-study-supporting-long-life-sensor-design-for-implantable-continuous-blood-glucose-monitoring Hawaii Health Digest en PressRelease 2026-04-21T12:00:00+00:00 Glucotrack Announces Publication of Peer-Reviewed Study Supporting Long-Life Sensor Design for Implantable Continuous Blood Glucose Monitoring Technology https://ml.globenewswire.com/media/3e47bd1b-0cc6-4104-b91d-0ddb9f30f4cc/small/gt-logo-png.png https://www.hawaiihealthdigest.com/article/907126942-calidi-biotherapeutics-presents-new-data-on-its-lead-asset-cld-401-at-the-aacr-annual-meeting-in-april-2026 Hawaii Health Digest en PressRelease 2026-04-21T12:00:00+00:00 Calidi Biotherapeutics Presents New Data on Its Lead Asset CLD-401 at the AACR Annual Meeting in April 2026 https://ml.globenewswire.com/media/9e574b79-be62-4805-a4b4-cb0b7dcc5fbd/small/calidibiotherapeutics-logo-2x-jpg.jpg https://www.hawaiihealthdigest.com/article/907127048-cogent-biosciences-announces-oral-presentation-of-positive-phase-3-peak-trial-in-gastrointestinal-stromal-tumors-gist-at-the-2026-american-society Hawaii Health Digest en PressRelease 2026-04-21T12:00:00+00:00 Cogent Biosciences Announces Oral Presentation of Positive Phase 3 PEAK Trial in Gastrointestinal Stromal Tumors (GIST) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting https://ml.globenewswire.com/media/2b8cbfab-a4de-4e17-bdd6-7ef597a95d2e/small/cogent-biosciences-logo-rgb-png.png https://www.hawaiihealthdigest.com/article/907127417-humacyte-announces-israeli-ministry-of-health-acceptance-of-marketing-authorization-application-for-symvess-for-vascular-trauma-repair Hawaii Health Digest en PressRelease 2026-04-21T12:00:00+00:00 Humacyte Announces Israeli Ministry of Health Acceptance of Marketing Authorization Application for Symvess® for Vascular Trauma Repair https://ml.globenewswire.com/media/e81aff26-ead8-404d-aebb-159b45c3e7b1/small/huma-logo-png.png https://www.hawaiihealthdigest.com/article/907128279-vystar-and-r3alm-launch-r3alm-com-following-strategic-transaction Hawaii Health Digest en PressRelease 2026-04-21T12:00:00+00:00 Vystar and R3alm Launch R3alm.com Following Strategic Transaction https://ml.globenewswire.com/media/08188699-078a-4d6e-ae46-c56120bb0435/small/logo-jpg.jpg https://www.hawaiihealthdigest.com/article/907128499-biorestorative-therapies-announces-strategic-partnership-with-global-dermatology-leader-dr-david-j-goldberg-to-lead-clinical-evaluation-and-seek Hawaii Health Digest en PressRelease 2026-04-21T12:00:00+00:00 BioRestorative Therapies Announces Strategic Partnership with Global Dermatology Leader Dr. David J. Goldberg to Lead Clinical Evaluation and Seek Multi-Channel Adoption of Its Regenerative BioCosmeceutical Platform https://ml.globenewswire.com/media/a9a09a16-9f91-466d-a0b4-2a7f2fd05ebe/small/logo-png.png https://www.hawaiihealthdigest.com/article/907128519-patchmd-appoints-bradley-keys-as-chief-marketing-officer Hawaii Health Digest en PressRelease 2026-04-21T12:00:00+00:00 PatchMD Appoints Bradley Keys as Chief Marketing Officer https://ml.globenewswire.com/media/832f8e23-1a68-4b10-b8aa-a35287e6c2e4/small/patchmd-red-logo-png.png https://www.hawaiihealthdigest.com/article/907128730-sotera-health-announces-first-quarter-2026-earnings-release-date Hawaii Health Digest en PressRelease 2026-04-21T11:46:03+00:00 Sotera Health Announces First-Quarter 2026 Earnings Release Date https://ml.globenewswire.com/media/a0ec722c-ad65-4f05-a8ae-bc1aa6cc4db4/small/sotera-png.png https://www.hawaiihealthdigest.com/article/907126642-plus-therapeutics-regains-compliance-with-nasdaq-minimum-bid-price-requirement Hawaii Health Digest en PressRelease 2026-04-21T11:30:00+00:00 Plus Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement  https://ml.globenewswire.com/media/92d7aa70-e37d-4870-bccf-d83b68ba5612/small/plus-logo-png.png https://www.hawaiihealthdigest.com/article/907127056-corvus-pharmaceuticals-to-host-investor-and-analyst-meeting-on-may-14-2026-to-highlight-soquelitinib-data-being-presented-at-the-society-for Hawaii Health Digest en PressRelease 2026-04-21T11:30:00+00:00 Corvus Pharmaceuticals to Host Investor and Analyst Meeting on May 14, 2026 to Highlight Soquelitinib Data Being Presented at the Society for Investigative Dermatology (SID) Annual Meeting https://ml.globenewswire.com/media/d05c16d1-5c24-4242-84b5-aea3951ca251/small/corvus-logo-large-jpg.jpg https://www.hawaiihealthdigest.com/article/907127289-briacell-presents-robust-anti-cancer-activity-of-bria-ots-in-preclinical-cancer-models Hawaii Health Digest en PressRelease 2026-04-21T11:30:00+00:00 BriaCell Presents Robust Anti-Cancer Activity of Bria-OTS+™ in Preclinical Cancer Models https://ml.globenewswire.com/media/6fd3be2a-b6a2-4f35-a39c-dfd88259d9d0/small/briacell-logo-square-a-jpg.jpg https://www.hawaiihealthdigest.com/article/907127504-annual-general-and-special-meeting-of-shareholders-to-be-held-may-7-2026 Hawaii Health Digest en PressRelease 2026-04-21T11:30:00+00:00 Annual General and Special Meeting of Shareholders to be held May 7, 2026 https://ml.globenewswire.com/media/c9abc2f4-efdc-40f6-921d-a5da048eda46/small/avicanna-logo-colour-withtm-01-png.png https://www.hawaiihealthdigest.com/article/907127716-medicenna-presents-positive-data-demonstrating-superior-safety-and-efficacy-potential-of-its-first-in-class-anti-pd-1-x-il-2-bifunctional-superkine Hawaii Health Digest en PressRelease 2026-04-21T11:30:00+00:00 Medicenna Presents Positive Data Demonstrating Superior Safety and Efficacy Potential of its First-in-Class anti-PD-1 x IL-2 Bifunctional Superkine MDNA113 at AACR 2026 https://ml.globenewswire.com/media/7e312e67-9924-4773-b548-47ed05d54904/small/new-logo-small-png.png https://www.hawaiihealthdigest.com/article/907127966-bpgbio-appoints-former-oxford-pro-vice-chancellor-for-innovation-chas-bountra-ph-d-as-executive-vice-president-and-chief-scientific-officer Hawaii Health Digest en PressRelease 2026-04-21T11:05:00+00:00 BPGbio Appoints Former Oxford Pro-Vice Chancellor for Innovation Chas Bountra, Ph.D., as Executive Vice President and Chief Scientific Officer https://ml.globenewswire.com/media/4a0c4e8a-8478-4161-9bc1-cfcdc41c9462/medium/bpgbio-appoints-chas-bountra-ph-d-as-executive-vice-presiden.png https://www.hawaiihealthdigest.com/article/907126696-standard-biotools-to-announce-first-quarter-2026-financial-results-on-may-5-2026 Hawaii Health Digest en PressRelease 2026-04-21T11:00:00+00:00 Standard BioTools to Announce First Quarter 2026 Financial Results on May 5, 2026 https://ml.globenewswire.com/media/122934c3-b763-4386-89d1-3047d0704c17/small/sbt-new-august-2022-logo.png https://www.hawaiihealthdigest.com/article/907126767-bioage-reports-positive-phase-1-data-for-bge-102-a-novel-oral-nlrp3-inhibitor-demonstrating-potential-best-in-class-reductions-in-hscrp Hawaii Health Digest en PressRelease 2026-04-21T11:00:00+00:00 BioAge Reports Positive Phase 1 Data for BGE-102, a Novel Oral NLRP3 Inhibitor, Demonstrating Potential Best-in-Class Reductions in hsCRP https://ml.globenewswire.com/media/d6df9eb5-87f7-4e2e-b503-8a7d8651428e/small/bioage-dark-logo-white-bg-500x500-png.png https://www.hawaiihealthdigest.com/article/907127293-eupraxia-pharmaceuticals-reports-positive-nine-month-tissue-health-and-symptom-data-from-the-highest-dose-cohort-in-its-ongoing-phase-1b-2a-resolve Hawaii Health Digest en PressRelease 2026-04-21T11:00:00+00:00 Eupraxia Pharmaceuticals Reports Positive Nine-Month Tissue Health and Symptom Data from the Highest Dose Cohort in its Ongoing Phase 1b/2a RESOLVE Trial in Eosinophilic Esophagitis  https://ml.globenewswire.com/media/0b2bbe4b-1cf9-402e-8ea6-22c0043f310a/small/eupraxia-color-med-res-01-jpg.jpg https://www.hawaiihealthdigest.com/article/907127564-rezolute-to-present-results-from-its-phase-3-sunrize-study-in-congenital-hyperinsulinism-at-the-pediatric-endocrine-society-pes-annual-meeting Hawaii Health Digest en PressRelease 2026-04-21T11:00:00+00:00 Rezolute to Present Results from its Phase 3 sunRIZE Study in Congenital Hyperinsulinism at the Pediatric Endocrine Society (PES) Annual Meeting https://ml.globenewswire.com/media/bbe03de3-6870-4230-b875-d8965a3d1b97/small/rezolute-jpg.jpg https://www.hawaiihealthdigest.com/article/907127978-kala-bio-celebrates-trump-executive-order-as-game-changer-for-psychedelic-medicine Hawaii Health Digest en PressRelease 2026-04-21T11:00:00+00:00 Kala Bio Celebrates Trump Executive Order as Game-Changer for Psychedelic Medicine https://ml.globenewswire.com/media/15db4366-93ba-40fa-b80d-58cbdde3496e/small/kala-bio-logo-jpg.jpg https://www.hawaiihealthdigest.com/article/907128029-xortx-meets-nasdaq-continued-listing-requirements Hawaii Health Digest en PressRelease 2026-04-21T11:00:00+00:00 XORTX Meets Nasdaq Continued Listing Requirements https://ml.globenewswire.com/media/9898c4f8-b373-438a-abfa-709c4372a061/small/xortx-logo-jpg.jpg https://www.hawaiihealthdigest.com/article/907128063-independent-nonclinical-research-on-lasofoxifene-presented-at-american-association-for-cancer-research-annual-meeting-2026-consistent-with-leonabio-s Hawaii Health Digest en PressRelease 2026-04-21T11:00:00+00:00 Independent Nonclinical Research on Lasofoxifene Presented at American Association for Cancer Research Annual Meeting 2026 Consistent with LeonaBio’s Data https://ml.globenewswire.com/media/84ac024a-139b-463f-a43f-ed787a66c0fd/small/image1-jpg.jpg https://www.hawaiihealthdigest.com/article/907128135-aavantgarde-announces-completion-of-recruitment-in-stella-natural-history-study Hawaii Health Digest en PressRelease 2026-04-21T11:00:00+00:00 AAVantgarde announces completion of recruitment in STELLA natural history study https://ml.globenewswire.com/media/e7ffd915-8158-436d-b9fe-8db1cb3597ce/small/logo-png.png https://www.hawaiihealthdigest.com/article/907117183-biontech-to-report-first-quarter-2026-financial-results-and-corporate-update-on-may-5-2026 Hawaii Health Digest en PressRelease 2026-04-21T10:45:00+00:00 BioNTech to Report First Quarter 2026 Financial Results and Corporate Update on May 5, 2026 https://ml-eu.globenewswire.com/media/b9e2e00e-f790-4d54-a01f-4c85716b01bd/small/190705-biontech-logo-rgb-dark-green-preferred-0-png.png https://www.hawaiihealthdigest.com/article/907117253-biontech-ver-ffentlicht-am-5-mai-2026-ergebnisse-f-r-das-erste-quartal-2026-und-informiert-ber-operativen-fortschritt Hawaii Health Digest en PressRelease 2026-04-21T10:45:00+00:00 BioNTech veröffentlicht am 5. Mai 2026 Ergebnisse für das erste Quartal 2026 und informiert über operativen Fortschritt https://ml-eu.globenewswire.com/media/b9e2e00e-f790-4d54-a01f-4c85716b01bd/small/ https://www.hawaiihealthdigest.com/article/907117929-avricore-health-achieves-milestones-and-outlines-uk-expansion-roadmap-for-healthtab-platform Hawaii Health Digest en PressRelease 2026-04-21T10:30:00+00:00 Avricore Health Achieves Milestones and Outlines UK Expansion Roadmap for HealthTab™ Platform https://ml.globenewswire.com/media/a3e47a88-fedc-4db4-969f-5fe1f028c54a/small/avicorelogo-png.png https://www.hawaiihealthdigest.com/article/907117341-cj-partners Hawaii Health Digest en PressRelease 2026-04-21T10:00:00+00:00 ダークホース・コンサルティング・グループ、CJ PARTNERS株式会社の買収によりアジア地域でのプレゼンスを強化 https://ml.globenewswire.com/media/b96e7c60-949b-4a7d-9d4e-8d9766cf8c87/small/2025-dhcg-logo-color-jpg.jpg https://www.hawaiihealthdigest.com/article/907117404-dark-horse-consulting-group-s-acquisition-of-cj-partners-provides-regional-expansion Hawaii Health Digest en PressRelease 2026-04-21T10:00:00+00:00 Dark Horse Consulting Group’s Acquisition of CJ PARTNERS Provides Regional Expansion https://ml.globenewswire.com/media/b96e7c60-949b-4a7d-9d4e-8d9766cf8c87/small/2025-dhcg-logo-color-jpg.jpg https://www.hawaiihealthdigest.com/article/907117621-hyalex-orthopaedics-announces-fda-510-k-clearance-of-the-hyalex-slalom-mtp-hemiarthroplasty-system Hawaii Health Digest en PressRelease 2026-04-21T10:00:00+00:00 Hyalex Orthopaedics Announces FDA 510(k) Clearance of the HYALEX Slalom™ MTP Hemiarthroplasty System https://ml.globenewswire.com/media/2c148840-120a-41be-af54-0ad73f8a4f6b/small/hyalex-logo-vector-recreated-white-border-png.png https://www.hawaiihealthdigest.com/article/907117962-nobel-potential-discovery-from-vectorbuilder-scientists-reveals-fundamental-mechanisms-of-development Hawaii Health Digest en PressRelease 2026-04-21T10:00:00+00:00 Nobel-Potential Discovery from VectorBuilder Scientists Reveals Fundamental Mechanisms of Development https://ml.globenewswire.com/media/051ef275-dc49-4fe6-bf1c-5736d994e6d3/small/vectorbuilder-logo-en-png.png https://www.hawaiihealthdigest.com/article/907117969-preclinical-data-of-novel-b7-h3-adc-icp-b794-unveiled-at-2026-aacr-demonstrating-superior-anti-tumor-activity-and-safety Hawaii Health Digest en PressRelease 2026-04-21T10:00:00+00:00 Preclinical Data of Novel B7-H3 ADC ICP-B794 Unveiled at 2026 AACR, Demonstrating Superior Anti-Tumor Activity and Safety https://ml.globenewswire.com/media/2dc70b00-a0b0-4d85-adef-2717a7067aec/small/innocare-eng-logo-horizontal-png.png https://www.hawaiihealthdigest.com/article/907108228-promatix-biosciences-highlights-the-power-of-its-logic-gated-proteomics-driven-bispecific-discovery-platform-to-expand-the-tumour-selective-target Hawaii Health Digest en PressRelease 2026-04-21T09:00:00+00:00 Promatix Biosciences Highlights the Power of its Logic-Gated Proteomics-Driven Bispecific Discovery Platform to Expand the Tumour-Selective Target Space for Next-Generation ADCs at AACR 2026 https://ml.globenewswire.com/media/9974c756-5f06-489e-adfb-6d302f15607d/small/promatix-curve-4c-rgb-png.png https://www.hawaiihealthdigest.com/article/907091007-xeltis-receives-ce-mark-for-axess-its-axess-hemodialysis-conduit-as-it-moves-to-commercialization Hawaii Health Digest en PressRelease 2026-04-21T07:30:00+00:00 Xeltis receives CE mark for aXess™, its aXess hemodialysis conduit™, as it moves to commercialization https://ml-eu.globenewswire.com/media/dee0d6ab-8850-4503-bdcd-ede435e96729/small/xeltis-youtube-logo-high-res-002-png.png https://www.hawaiihealthdigest.com/article/907083330-grady-manual-therapy-ltd-champions-exercise-is-medicine-to-deliver-professional-sports-health-care-to-everyday-athletes-in-hong-kong Hawaii Health Digest en PressRelease 2026-04-21T06:17:00+00:00 Grady Manual Therapy Ltd Champions "Exercise is Medicine" to Deliver Professional Sports Health Care to Everyday Athletes in Hong Kong https://ml.globenewswire.com/media/c633e084-7b0e-4176-9e88-920252646685/medium/grady-manual-therapy.jpg https://www.hawaiihealthdigest.com/article/907082963-groundbreaking-approaches-such-as-cell-therapies-on-the-horizon-for-transformation-of-neural-hearing-loss-rinri-therapeutics-review1-shows Hawaii Health Digest en PressRelease 2026-04-21T06:10:51+00:00 Groundbreaking approaches such as cell therapies on the horizon for transformation of neural hearing loss, Rinri Therapeutics’ review1 shows https://ml-eu.globenewswire.com/media/b9ae33a8-504d-4b72-af5c-e7cc32499f9e/small/news-hold-700x441-png.png https://www.hawaiihealthdigest.com/article/907082843-amphista-therapeutics-presents-the-discovery-characterisation-and-chemical-structure-of-amx-883-an-orally-bioavailable-highly-potent-and-selective Hawaii Health Digest en PressRelease 2026-04-21T06:00:00+00:00 Amphista Therapeutics presents the discovery, characterisation and chemical structure of AMX-883, an orally bioavailable, highly potent and selective DCAF16 degrader of BRD9 at AACR 2026 https://ml-eu.globenewswire.com/media/d3d2174f-591e-4e13-9a89-363dcbfe5c68/small/amphista-horiz-logo-rgb-1500px-png.png https://www.hawaiihealthdigest.com/article/907074659-addex-gabab-pam-candidate-demonstrates-robust-anti-tussive-activity-in-non-human-primate-chronic-cough-model Hawaii Health Digest en PressRelease 2026-04-21T05:00:00+00:00 Addex GABAB PAM Candidate Demonstrates Robust Anti-Tussive Activity in Non-Human Primate Chronic Cough Model https://ml-eu.globenewswire.com/media/e6c12443-4244-46f9-909c-5ab241bbea41/small/logo-jpg.jpg https://www.hawaiihealthdigest.com/article/907057861-rapid-nutrition-establishes-flagship-platform-to-strengthen-multi-channel-strategy-in-australia Hawaii Health Digest en PressRelease 2026-04-21T03:05:00+00:00 Rapid Nutrition Establishes Flagship Platform to Strengthen Multi-Channel Strategy in Australia https://ml-eu.globenewswire.com/media/f5152816-94d7-4584-a49f-05ae66a44bf0/small/rapid-jpg.jpg https://www.hawaiihealthdigest.com/article/907042110-enjoin-launches-technology-first-rebrand-for-scalable-revenue-integrity Hawaii Health Digest en PressRelease 2026-04-21T01:07:48+00:00 Enjoin Launches Technology-First Rebrand For Scalable Revenue Integrity https://ml.globenewswire.com/media/89b4ff0a-3ba9-4083-9a13-a7e4b0a07d6f/medium/enjoin-launches-technology-first-rebrand-for-scalable-revenu.png https://www.hawaiihealthdigest.com/article/907035057-moonbuddy-kids-breathing-guidance-under-investigation-tactile-breathwork-device-claims-get-reviewed Hawaii Health Digest en PressRelease 2026-04-21T00:53:42+00:00 Moonbuddy Kids Breathing Guidance Under Investigation: Tactile Breathwork Device Claims Get Reviewed https://zingfast.com/wp-content/uploads/2026/04/Moonbuddy-Kids-Breathing-Guidance.jpg https://www.hawaiihealthdigest.com/article/907035030-trt-uk-what-is-trt-and-who-should-take-a-trt-test-a-complete-uk-guide Hawaii Health Digest en PressRelease 2026-04-21T00:47:03+00:00 TRT UK - What Is TRT and Who Should Take a TRT Test? A Complete UK Guide https://zingfast.com/wp-content/uploads/2026/04/TRT-UK.png https://www.hawaiihealthdigest.com/article/907034966-snorerx-anti-snoring-mouthpiece-claims-evaluated-doctor-recommended-adjustable-mouthguard-for-safer-airway-breathing-overnight Hawaii Health Digest en PressRelease 2026-04-21T00:35:09+00:00 SnoreRX Anti-Snoring Mouthpiece Claims Evaluated: Doctor-Recommended Adjustable Mouthguard for Safer Airway Breathing Overnight https://zingfast.com/wp-content/uploads/2026/04/SnoreRX-Anti-Snoring-Mouthpiece.jpg https://www.hawaiihealthdigest.com/article/907021337-moonbird-claims-evaluated-guided-breathing-therapy-device-for-meditation-like-calming-benefits-for-relaxation-sleep-support Hawaii Health Digest en PressRelease 2026-04-20T23:13:35+00:00 Moonbird Claims Evaluated: Guided Breathing Therapy Device for Meditation-Like Calming Benefits for Relaxation & Sleep Support https://zingfast.com/wp-content/uploads/2026/04/Moodbird.jpg https://www.hawaiihealthdigest.com/article/907021232-essential-pharma-renaissance-pharma-limited-daretabart-hu1418k322a-fda-ind Hawaii Health Digest en PressRelease 2026-04-20T23:00:00+00:00 Essential Pharma 旗下公司 Renaissance Pharma Limited 用于治疗高危神经母细胞瘤的 Daretabart (hu1418K322A) 获得 FDA 快速通道认定，并通过 IND 审评 https://ml-eu.globenewswire.com/media/31276511-f379-4a7a-90b6-af9fc9ac2aa0/small/66795319ca361c8d044a2cc6-essential-pharma-master-logo-png.png https://www.hawaiihealthdigest.com/article/907015146-provectus-biopharmaceuticals-to-hold-2026-annual-meeting-of-stockholders-at-perkins-place-its-planned-new-headquarters-in-knoxville-tennessee Hawaii Health Digest en PressRelease 2026-04-20T22:09:00+00:00 Provectus Biopharmaceuticals to Hold 2026 Annual Meeting of Stockholders at Perkins Place, Its Planned New Headquarters in Knoxville, Tennessee https://ml.globenewswire.com/media/7cd1d796-f4d3-43f7-8e2b-eb51dc04a073/small/new-logo-png.png https://www.hawaiihealthdigest.com/article/907007985-enara-bio-presents-first-in-class-darkfox-targeting-bispecific-t-cell-engager-ena101-in-oral-presentation-at-aacr-2026-showcasing-breakthrough Hawaii Health Digest en PressRelease 2026-04-20T21:30:00+00:00 Enara Bio Presents First-in-Class DARKFOX-Targeting Bispecific T Cell Engager ENA101 in Oral Presentation at AACR 2026, Showcasing Breakthrough Potential in Solid Tumor Immunotherapy https://ml-eu.globenewswire.com/media/e94da9bc-a053-4a2f-8d29-c57dba971380/small/logo-png.PNG https://www.hawaiihealthdigest.com/article/907008228-aktualisierung-bvi-gibt-bekannt-dass-virtuoso-eine-neue-chirurgische-plattform-mit-doppelfunktion-die-ce-kennzeichnung-gem-eu-mdr-erhalten Hawaii Health Digest en PressRelease 2026-04-20T21:28:54+00:00 AKTUALISIERUNG -- BVI gibt bekannt, dass Virtuoso®, eine neue chirurgische Plattform mit Doppelfunktion, die CE-Kennzeichnung gemäß EU-MDR erhalten hat https://ml.globenewswire.com/media/NjNkNTUyMTQtMGZiYS00MTczLTkxNDYtN2IxMmI2YTU0ZmMyLTEyNjQwMzItMjAyNi0wNC0yMC1kZQ==/tiny/BVI-Medical-Inc-.png https://www.hawaiihealthdigest.com/article/907008243-mise-jour-bvi-annonce-l-obtention-du-marquage-ce-au-titre-du-r-glement-europ-en-sur-les-dispositifs-m-dicaux-pour-virtuoso-une-toute-nouvelle Hawaii Health Digest en PressRelease 2026-04-20T21:28:54+00:00 MISE À JOUR -- BVI annonce l’obtention du marquage CE au titre du Règlement européen sur les dispositifs médicaux pour Virtuoso®, une toute nouvelle plateforme chirurgicale à double fonction https://ml.globenewswire.com/media/NjNkNTUyMTQtMGZiYS00MTczLTkxNDYtN2IxMmI2YTU0ZmMyLTEyNjQwMzItMjAyNi0wNC0yMC1mcg==/tiny/BVI-Medical-Inc-.png https://www.hawaiihealthdigest.com/article/907008038-bastiongpt-named-top-ai-platform-for-clinical-psychology-report-writing Hawaii Health Digest en PressRelease 2026-04-20T21:13:00+00:00 BastionGPT Named Top AI Platform for Clinical Psychology Report Writing https://pressranger.s3.us-west-1.amazonaws.com/3234411/Top-AI-Report-Writers-Hero.jpg https://www.hawaiihealthdigest.com/article/907007986-junshi-biosciences-presents-results-from-js207-pd-1-vegf-bsab-phase-2-combo-studies-and-js212-egfr-her3-adc-fih-phase-1-2-study-at-aacr-2026 Hawaii Health Digest en PressRelease 2026-04-20T21:00:00+00:00 Junshi Biosciences Presents Results from JS207 (PD-1/VEGF BsAb) Phase 2 Combo Studies and JS212 (EGFR/HER3 ADC) FIH Phase 1/2 Study at AACR 2026 https://ml.globenewswire.com/media/815f9c91-bb76-4c14-b3e9-0685275600cc/small/junshi-topalliance-logo-png.png https://www.hawaiihealthdigest.com/article/907000723-cvrx-announces-nomination-of-michael-dale-for-election-to-the-board-of-directors Hawaii Health Digest en PressRelease 2026-04-20T20:30:00+00:00 CVRx Announces Nomination of Michael Dale for Election to the Board of Directors https://ml.globenewswire.com/media/04c4feba-7841-4ac8-8ca5-6c03be383a0e/small/cvrx-outsmart-the-heart-logo-rgb-blue-png.png https://www.hawaiihealthdigest.com/article/907000759-jatt-ii-acquisition-corp-announces-closing-of-60-000-000-initial-public-offering Hawaii Health Digest en PressRelease 2026-04-20T20:30:00+00:00 JATT II Acquisition Corp Announces Closing of $60,000,000 Initial Public Offering https://ml.globenewswire.com/media/6124930b-cb04-4490-8614-def6ec191d09/small/1b-for-pr-jatt-2-png.png https://www.hawaiihealthdigest.com/article/907000697-spectral-ai-announces-annual-meeting-of-stockholders Hawaii Health Digest en PressRelease 2026-04-20T20:15:00+00:00 Spectral AI Announces Annual Meeting of Stockholders https://ml.globenewswire.com/media/e51098e6-329d-4efc-acb5-a92a6b8f2a5d/small/spectral-ai-logo-jpg.jpg https://www.hawaiihealthdigest.com/article/907000898-si-bone-to-report-first-quarter-2026-financial-results-on-may-11-2026 Hawaii Health Digest en PressRelease 2026-04-20T20:09:00+00:00 SI-BONE To Report First-Quarter 2026 Financial Results on May 11, 2026 https://ml.globenewswire.com/media/1630843d-d109-4819-9c6f-455c684690ba/small/sibn-logo-jpg.jpg https://www.hawaiihealthdigest.com/article/907001325-bbot-granted-u-s-fda-fast-track-designation-for-bbo-11818-for-the-treatment-of-adult-patients-with-advanced-kras-mutant-pancreatic-ductal Hawaii Health Digest en PressRelease 2026-04-20T20:06:48+00:00 BBOT Granted U.S. FDA Fast Track Designation for BBO-11818 for the Treatment of Adult Patients with Advanced KRAS-Mutant Pancreatic Ductal Adenocarcinoma https://ml.globenewswire.com/media/f5f2b913-06aa-4e1d-9368-55ff15fb3bd6/small/bbot-fullcolor-rgb-png.png https://www.hawaiihealthdigest.com/article/906998846-abivax-annual-ordinary-and-extraordinary-general-meeting-of-may-11-2026-availability-of-the-preparatory-documents Hawaii Health Digest en PressRelease 2026-04-20T20:05:00+00:00 Abivax Annual Ordinary and Extraordinary General Meeting of May 11, 2026 Availability of the Preparatory Documents https://ml-eu.globenewswire.com/media/5470cd7e-c1fe-402f-8673-925c82bbd2fb/small/abivax-logo-rgb-png.png https://www.hawaiihealthdigest.com/article/906998866-regeneron-announces-investor-conference-presentations Hawaii Health Digest en PressRelease 2026-04-20T20:05:00+00:00 Regeneron Announces Investor Conference Presentations https://ml.globenewswire.com/media/add5ebc7-88c9-49dc-8834-abbb07c622d1/small/regeneron-logo-jpg.jpg https://www.hawaiihealthdigest.com/article/907000274-geron-corporation-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Hawaii Health Digest en PressRelease 2026-04-20T20:05:00+00:00 Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/e184bb51-5636-436e-8964-15613f24ca1f/small/geron-logo-jpg.jpg https://www.hawaiihealthdigest.com/article/907000281-ceribell-to-report-first-quarter-2026-financial-results-on-may-11-2026 Hawaii Health Digest en PressRelease 2026-04-20T20:05:00+00:00 Ceribell to Report First Quarter 2026 Financial Results on May 11, 2026 https://ml.globenewswire.com/media/937c5c00-41f8-45ff-b294-5f9c3f6ab2cf/small/cbll-square-logo-500x500-png.png https://www.hawaiihealthdigest.com/article/907000699-amwell-to-report-first-quarter-2026-operating-results Hawaii Health Digest en PressRelease 2026-04-20T20:05:00+00:00 Amwell® to report first quarter 2026 operating results https://ml.globenewswire.com/media/ff1989f5-0a6a-4e00-99dc-cb29a818aca5/small/amwell-logo-blue-2023-v02-rgb-2-png.png https://www.hawaiihealthdigest.com/article/907000869-trevi-therapeutics-announces-closing-of-173-million-underwritten-offering-and-full-exercise-by-underwriters-of-option-to-purchase-additional-shares Hawaii Health Digest en PressRelease 2026-04-20T20:05:00+00:00 Trevi Therapeutics Announces Closing of $173 Million Underwritten Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares https://ml.globenewswire.com/media/b97e9d57-6e8e-4570-87da-ea38c273f7c8/small/trevi-logo-jpg.jpg https://www.hawaiihealthdigest.com/article/907000933-equillium-to-participate-in-oppenheimer-s-2026-innovation-on-the-island-event Hawaii Health Digest en PressRelease 2026-04-20T20:05:00+00:00 Equillium to Participate in Oppenheimer’s 2026 Innovation on the Island Event https://ml.globenewswire.com/media/14ce766d-e697-461f-a27c-c1ee49c0eeff/small/equillium-logo-360x180-jpg.jpg https://www.hawaiihealthdigest.com/article/907001167-kailera-announces-closing-of-initial-public-offering-and-full-exercise-of-underwriters-option-to-purchase-additional-shares Hawaii Health Digest en PressRelease 2026-04-20T20:05:00+00:00 Kailera Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares https://ml.globenewswire.com/media/c0b33a3d-0c2b-45b0-ace8-6ff585b41339/small/kailera-logo-png.png https://www.hawaiihealthdigest.com/article/907000930-clearmind-medicine-welcomes-president-trump-s-executive-order-as-a-historic-catalyst-for-psychedelic-innovation-and-veteran-mental-health-care Hawaii Health Digest en PressRelease 2026-04-20T20:03:00+00:00 Clearmind Medicine Welcomes President Trump’s Executive Order as a Historic Catalyst for Psychedelic Innovation and Veteran Mental Health Care https://ml.globenewswire.com/media/bd17cbf4-8124-4f86-8a4c-1fafbb6785af/small/logo-jpg.jpg https://www.hawaiihealthdigest.com/article/907000821-fibrobiologics-compliant-with-all-nasdaq-listing-requirements Hawaii Health Digest en PressRelease 2026-04-20T20:01:00+00:00 FibroBiologics Compliant with All Nasdaq Listing Requirements https://ml.globenewswire.com/media/720fe0fe-52b4-4ccc-a5ad-95d4288f1df2/small/fibrobiologics-logo-2022-jpg.jpg https://www.hawaiihealthdigest.com/article/907000730-cytokinetics-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Hawaii Health Digest en PressRelease 2026-04-20T20:00:00+00:00 Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) https://ml.globenewswire.com/media/52e2be9f-e9e3-43af-a747-123fdcac4253/small/cytokinetics-png.png https://www.hawaiihealthdigest.com/article/907000929-nadp-appoints-first-dentist-to-lead-dental-informatics-program Hawaii Health Digest en PressRelease 2026-04-20T20:00:00+00:00 NADP appoints first dentist to lead dental informatics program https://ml.globenewswire.com/media/4a10cf41-2ae9-4a40-a33e-49e2ed33e40f/small/nadp-logo-horizontal-2024-final-jpg.jpg https://www.hawaiihealthdigest.com/article/907000963-kfsh-se-une-al-c3-davos-of-healthcare-2026-en-sunnyvale-california-como-socio-estrat-gico-global Hawaii Health Digest en PressRelease 2026-04-20T19:51:30+00:00 KFSH se une al C3 Davos of Healthcare™ 2026 en Sunnyvale, California, como socio estratégico global https://ml.globenewswire.com/media/9f73a943-28c0-4ee7-a796-2407051abbe7/small/logo-kfshrc-png.png https://www.hawaiihealthdigest.com/article/907000964-kfsh-participa-da-c3-davos-of-healthcare-2026-em-sunnyvale-calif-rnia-como-parceira-estrat-gica-global Hawaii Health Digest en PressRelease 2026-04-20T19:51:30+00:00 KFSH Participa da C3 Davos of Healthcare™ 2026 em Sunnyvale, Califórnia, como Parceira Estratégica Global https://ml.globenewswire.com/media/9f73a943-28c0-4ee7-a796-2407051abbe7/small/logo-kfshrc-png.png https://www.hawaiihealthdigest.com/article/906993005-ab-science-nouvelle-publication-sur-medrxiv-d-montrant-des-b-n-fices-substantiels-en-termes-de-survie-et-de-qualit-de-vie-pr-serv-e-avec-le Hawaii Health Digest en PressRelease 2026-04-20T19:32:18+00:00 AB Science : Nouvelle publication sur medrxiv démontrant des bénéfices substantiels en termes de survie et de qualité de vie préservée avec le masitinib chez les patients atteints de SLA https://ml-eu.globenewswire.com/media/90d86a0e-7ea1-47ab-99d9-69985fa76ce0/small/ https://www.hawaiihealthdigest.com/article/906993019-ab-science-new-publication-on-medrxiv-demonstrating-substantial-survival-benefits-and-preserved-quality-of-life-with-masitinib-in-als-patients Hawaii Health Digest en PressRelease 2026-04-20T19:32:18+00:00 AB Science: New publication on medrxiv demonstrating substantial survival benefits and preserved quality of life with masitinib in ALS patients https://ml-eu.globenewswire.com/media/90d86a0e-7ea1-47ab-99d9-69985fa76ce0/small/logo-jpg.jpg https://www.hawaiihealthdigest.com/article/906987447-flyte-emerges-as-direct-beneficiary-as-rising-fuel-costs-drive-airline-retreat-from-short-haul-routes Hawaii Health Digest en PressRelease 2026-04-20T18:50:00+00:00 FLYTE EMERGES AS DIRECT BENEFICIARY AS RISING FUEL COSTS DRIVE AIRLINE RETREAT FROM SHORT-HAUL ROUTES https://ml.globenewswire.com/media/cb9f10dc-be78-4c7c-a235-81bfdd77f03c/small/catheterlogo-jpg.jpg https://www.hawaiihealthdigest.com/article/906982674-lung-cancer-therapeutics-market-to-reach-49-5-billion-by-2030-driven-by-rising-cancer-incidence-and-r-d-investment-surge Hawaii Health Digest en PressRelease 2026-04-20T18:19:26+00:00 Lung Cancer Therapeutics Market to Reach $49.5 Billion by 2030, Driven by Rising Cancer Incidence and R&D Investment Surge https://ml.globenewswire.com/media/d0c282b6-d496-45a8-a941-33fa5c3e824c/small/bcc-logo-1200-630-png.png https://www.hawaiihealthdigest.com/article/906982665-herz-p1-smart-bpm-under-investigation-clinical-grade-blood-pressure-monitoring-for-valuable-at-home-health-tracking-support Hawaii Health Digest en PressRelease 2026-04-20T18:11:55+00:00 Herz P1 Smart BPM Under Investigation: Clinical-Grade Blood Pressure Monitoring for Valuable At-Home Health Tracking Support https://zingfast.com/wp-content/uploads/2026/04/Herz-P1-Smart-BPM.jpg https://www.hawaiihealthdigest.com/article/906982687-viriflow-claims-evaluated-the-prostate-supporting-formula-for-men-that-actually-works-in-viri-flow-drops-reviewed Hawaii Health Digest en PressRelease 2026-04-20T18:09:54+00:00 ViriFlow Claims Evaluated: The Prostate-Supporting Formula for Men That Actually Works in Viri Flow Drops Reviewed https://zingfast.com/wp-content/uploads/2026/04/ViriFlow-1.jpg https://www.hawaiihealthdigest.com/article/906972983-lirum-therapeutics-announces-positive-lx-101-data-selected-for-presentation-at-the-2026-american-association-for-cancer-research-aacr-annual-meeting Hawaii Health Digest en PressRelease 2026-04-20T17:00:00+00:00 Lirum Therapeutics Announces Positive LX-101 Data Selected for Presentation at the 2026 American Association for Cancer Research (AACR) Annual Meeting https://ml.globenewswire.com/media/09223099-97d9-4c04-8b22-ce639c0fd876/small/lirum-therapeutics-inc-logo-jpg.jpg https://www.hawaiihealthdigest.com/article/906972380-stiltz-homelifts-opens-first-u-s-showroom-in-denver-showcasing-innovative-home-elevator-solutions Hawaii Health Digest en PressRelease 2026-04-20T16:21:48+00:00 Stiltz Homelifts Opens First U.S. Showroom in Denver, Showcasing Innovative Home Elevator Solutions https://ml.globenewswire.com/media/NTcyZDQ0MTQtY2I4OC00NWE0LTlhZDQtZmI5MzRmODc5N2E4LTUwMDE1MTA0My0yMDI2LTA0LTIwLWVu/tiny/Stiltz-Homelifts.png https://www.hawaiihealthdigest.com/article/906967650-genfit-publication-of-the-2026-extra-financial-report-fiscal-year-2025 Hawaii Health Digest en PressRelease 2026-04-20T16:00:00+00:00 GENFIT: Publication of the 2026 Extra-Financial Report (fiscal year 2025) https://ml-eu.globenewswire.com/media/NWQ4ZDk0NzEtNGJjYy00N2I0LTljZTgtNTVlNGMzMWE3NmIyLTEwMTEyNjgtMjAyNi0wNC0yMC1lbg==/tiny/GENFIT-S-A-.png https://www.hawaiihealthdigest.com/article/906967654-genfit-publication-du-rapport-de-performance-extra-financi-re-2026-exercice-2025 Hawaii Health Digest en PressRelease 2026-04-20T16:00:00+00:00 GENFIT : Publication du rapport de performance extra-financière 2026 (exercice 2025) https://ml-eu.globenewswire.com/media/NWQ4ZDk0NzEtNGJjYy00N2I0LTljZTgtNTVlNGMzMWE3NmIyLTEwMTEyNjgtMjAyNi0wNC0yMC1mcg==/tiny/GENFIT-S-A-.png https://www.hawaiihealthdigest.com/article/906967984-une-analyse-m-dico-conomique-la-premi-re-du-genre-montre-que-le-recours-pr-coce-des-tests-de-diagnostic-rapides-pour-soigner-le-sepsis-pourrait Hawaii Health Digest en PressRelease 2026-04-20T15:48:14+00:00 Une analyse médico-économique, la première du genre, montre que le recours précoce à des tests de diagnostic rapides pour soigner le sepsis pourrait sauver des milliers de vies au Canada et réduire les coûts du système de santé dans les pays du G… https://ml.globenewswire.com/media/a5be803c-994c-40a9-9736-fbddf2068664/small/ https://www.hawaiihealthdigest.com/article/906968109-first-of-its-kind-health-economic-analysis-shows-early-use-of-fast-diagnostics-in-sepsis-care-could-save-thousands-of-lives-in-canada-and-reduce Hawaii Health Digest en PressRelease 2026-04-20T15:48:14+00:00 First-of-its-Kind Health Economic Analysis Shows Early Use of Fast Diagnostics in Sepsis Care Could Save Thousands of Lives in Canada and Reduce Health System Costs Across G7 Countries https://ml.globenewswire.com/media/a5be803c-994c-40a9-9736-fbddf2068664/small/bmx-hi-res-png-png.png https://www.hawaiihealthdigest.com/article/906967981-allsup-employment-services-highlights-tax-incentives-for-employers-hiring-through-ticket-to-work-program Hawaii Health Digest en PressRelease 2026-04-20T15:45:44+00:00 Allsup Employment Services Highlights Tax Incentives For Employers Hiring Through Ticket To Work Program https://ml.globenewswire.com/media/NWExNjVhY2ItMGU4YS00MzU3LTgyNjItM2YyYWI1YjNlZTZiLTEwOTcwODEtMjAyNi0wNC0yMC1lbg==/tiny/Allsup.png https://www.hawaiihealthdigest.com/article/906967852-onward-medical-publishes-closing-of-bookbuild-offering Hawaii Health Digest en PressRelease 2026-04-20T15:45:00+00:00 ONWARD Medical Publishes Closing of Bookbuild Offering https://ml.globenewswire.com/media/a60261ec-0c66-4acb-8726-e567073990a2/small/onwardresized1-png.png https://www.hawaiihealthdigest.com/article/906963267-naomi-ruth-cohen-institute-for-mental-health-education-to-host-annual-conference-addressing-the-growing-crisis-of-loneliness Hawaii Health Digest en PressRelease 2026-04-20T15:15:51+00:00 Naomi Ruth Cohen Institute For Mental Health Education to Host Annual Conference Addressing the Growing Crisis of Loneliness https://ml.globenewswire.com/media/dbf190a7-e0c0-4b88-843a-d7e31bf57b45/small/the-chicago-school-logo.png https://www.hawaiihealthdigest.com/article/906958920-global-vascular-access-device-market-to-reach-usd-8-68-billion-by-2031-marketsandmarkets Hawaii Health Digest en PressRelease 2026-04-20T14:30:00+00:00 Global Vascular Access Device Market to Reach USD 8.68 Billion by 2031 | MarketsandMarkets™ https://ml.globenewswire.com/media/afcc5182-4ae0-43a8-a965-4351d590b7ed/small/mnm-logo-tm-jpg-jpg.JPG https://www.hawaiihealthdigest.com/article/906954710-alayacare-and-eitan-medical-partner-to-eliminate-manual-transcription-for-home-infusion-nurses Hawaii Health Digest en PressRelease 2026-04-20T14:14:14+00:00 AlayaCare and Eitan Medical partner to eliminate manual transcription for home infusion nurses https://ml.globenewswire.com/media/80920392-a416-454f-9f6c-c63983a6924e/medium/alayacare-and-eitan-medical-partner-to-eliminate-manual-tran.png https://www.hawaiihealthdigest.com/article/906954306-baba-appoints-former-mount-sinai-executive-director-to-lead-clinical-operations Hawaii Health Digest en PressRelease 2026-04-20T14:00:00+00:00 Baba Appoints Former Mount Sinai Executive Director to Lead Clinical Operations https://ml.globenewswire.com/media/1152e949-0f9a-4ff0-96e1-bcdae32214aa/small/baba-logo-blue-1-png.png https://www.hawaiihealthdigest.com/article/906954500-viewsml-secures-funding-to-accelerate-commercialization-of-ai-driven-virtual-biomarker-staining-platform Hawaii Health Digest en PressRelease 2026-04-20T14:00:00+00:00 ViewsML Secures Funding to Accelerate Commercialization of AI-Driven Virtual Biomarker Staining Platform https://ml.globenewswire.com/media/8484a3fc-fc06-4cd9-bcd5-2083fa5c8637/small/logo-horizontal-positive-png.png https://www.hawaiihealthdigest.com/article/906954630-bvi-announces-ce-mark-under-eu-mdr-for-virtuoso-a-brand-new-dual-function-surgical-platform Hawaii Health Digest en PressRelease 2026-04-20T14:00:00+00:00 BVI Announces CE Mark Under EU MDR for Virtuoso®, A Brand New Dual-Function Surgical Platform https://ml.globenewswire.com/media/0e7f0025-cd6d-4b42-9d31-9d16f1b74c40/small/bvi-logo-png.png https://www.hawaiihealthdigest.com/article/906954618-tilray-brands-marks-4-20-reaffirming-its-leadership-in-cannabis-and-commitment-to-advancing-medical-care Hawaii Health Digest en PressRelease 2026-04-20T13:56:27+00:00 Tilray Brands Marks 4/20, Reaffirming Its Leadership in Cannabis and Commitment to Advancing Medical Care https://ml.globenewswire.com/media/2dbf85bb-5e30-4623-8f9b-931442240c05/small/tilraybrands-logo-fullcolor-rbg-horiz-01-png.png https://www.hawaiihealthdigest.com/article/906950148-hinweis-zum-nichtbeachten-bvi-medical-inc Hawaii Health Digest en PressRelease 2026-04-20T13:46:44+00:00 HINWEIS ZUM NICHTBEACHTEN -- BVI Medical, Inc. https://ml.globenewswire.com/media/0e7f0025-cd6d-4b42-9d31-9d16f1b74c40/small/bvi-logo-png.png https://www.hawaiihealthdigest.com/article/906950152-avis-ignorer-bvi-medical-inc Hawaii Health Digest en PressRelease 2026-04-20T13:46:44+00:00 AVIS À IGNORER -- BVI Medical, Inc. https://ml.globenewswire.com/media/0e7f0025-cd6d-4b42-9d31-9d16f1b74c40/small/bvi-logo-png.png https://www.hawaiihealthdigest.com/article/906950084-3-2-bn-medical-radiation-shielding-market-forecasts-to-2034-rising-more-imaging-and-therapy-procedures-due-to-growing-chronic-diseases-and Hawaii Health Digest en PressRelease 2026-04-20T13:37:26+00:00 $3.2+ BN Medical Radiation Shielding Market Forecasts to 2034: Rising More Imaging and Therapy Procedures Due to Growing Chronic Diseases and Increasing Risk Awareness https://ml.globenewswire.com/media/1f4cf0ab-7d76-4136-a6dc-a5545f80f538/small/zion-market-research-jpg.jpg https://www.hawaiihealthdigest.com/article/906950102-vystar-enters-into-binding-letter-of-intent-to-acquire-50-interest-in-r3alm-inc Hawaii Health Digest en PressRelease 2026-04-20T13:22:43+00:00 Vystar Enters into Binding Letter of Intent to Acquire 50% Interest in R3alm Inc. https://ml.globenewswire.com/media/08188699-078a-4d6e-ae46-c56120bb0435/small/logo-jpg.jpg https://www.hawaiihealthdigest.com/article/906946311-anaptys-completes-separation-of-first-tracks-biotherapeutics-and-now-exclusively-manages-gsk-and-vanda-financial-collaborations Hawaii Health Digest en PressRelease 2026-04-20T13:15:00+00:00 Anaptys Completes Separation of First Tracks Biotherapeutics and Now Exclusively Manages GSK and Vanda Financial Collaborations https://ml.globenewswire.com/media/eb223f66-e7e0-4e0a-94e7-a3f7a06b13ab/small/anaptys-logo-png.png https://www.hawaiihealthdigest.com/article/906946313-first-tracks-biotherapeutics-debuts-on-nasdaq-to-advance-therapies-for-autoimmune-diseases Hawaii Health Digest en PressRelease 2026-04-20T13:15:00+00:00 First Tracks Biotherapeutics Debuts on Nasdaq to Advance Therapies for Autoimmune Diseases https://ml.globenewswire.com/media/7165e7cf-d98b-4a0f-90f3-3cd8f3a6b320/small/ftb-logo-png.png https://www.hawaiihealthdigest.com/article/906946476-intelligent-bio-solutions-initiates-validation-study-for-rapid-drug-screening-cartridge-targeting-70-faster-results Hawaii Health Digest en PressRelease 2026-04-20T13:15:00+00:00 Intelligent Bio Solutions Initiates Validation Study for Rapid Drug Screening Cartridge Targeting 70% Faster Results https://ml.globenewswire.com/media/d4eaef42-9420-48b7-8019-0285720d678c/small/ibs-primary-logo-blue-png.png https://www.hawaiihealthdigest.com/article/906945549-orion-pharma-s-odm-212-granted-orphan-drug-designation-in-mesothelioma-by-the-us-fda Hawaii Health Digest en PressRelease 2026-04-20T13:00:00+00:00 Orion Pharma’s ODM-212 Granted Orphan Drug Designation in Mesothelioma by the US FDA https://ml-eu.globenewswire.com/media/9e6a027a-eb6c-4e34-993e-b8295e6d598d/small/orionpharma-rgb-press-releases-jpg.jpg https://www.hawaiihealthdigest.com/article/906945573-orion-pharman-odm-212-molekyyli-on-saanut-fda-n-harvinaisl-kestatuksen-orphan-drug-designation-mesoteliooman-hoidossa Hawaii Health Digest en PressRelease 2026-04-20T13:00:00+00:00 Orion Pharman ODM-212-molekyyli on saanut FDA:n harvinaislääkestatuksen (Orphan Drug Designation) mesoteliooman hoidossa https://ml-eu.globenewswire.com/media/9e6a027a-eb6c-4e34-993e-b8295e6d598d/small/ https://www.hawaiihealthdigest.com/article/906945991-rpharmy-completes-soc-2-type-ii-audit-reinforcing-its-commitment-to-data-security-in-healthcare Hawaii Health Digest en PressRelease 2026-04-20T13:00:00+00:00 Rpharmy Completes SOC 2® Type II Audit, Reinforcing Its Commitment to Data Security in Healthcare https://ml.globenewswire.com/media/d4e2107a-158e-47f0-83ff-c3ff9cca678d/small/rpharmy-charcoal-logo-png.png https://www.hawaiihealthdigest.com/article/906946091-immuneering-presents-genetic-data-at-aacr-annual-meeting-demonstrating-mechanism-to-improve-durability-and-survival-supporting-use-of-atebimetinib-in Hawaii Health Digest en PressRelease 2026-04-20T13:00:00+00:00 Immuneering Presents Genetic Data at AACR Annual Meeting Demonstrating Mechanism to Improve Durability and Survival, Supporting Use of Atebimetinib in First-Line Pancreatic Cancer and Beyond https://ml.globenewswire.com/media/81d0c83f-ae53-4d6e-9c5e-d6963e02f29d/small/immuneering-logo-cropped-1-jpg.jpg https://www.hawaiihealthdigest.com/article/906946305-scilex-holding-company-announces-its-board-of-directors-approved-a-dividend-of-dream-bowl-i-meme-coin-tokens-to-holders-of-common-stock-and-other Hawaii Health Digest en PressRelease 2026-04-20T13:00:00+00:00 Scilex Holding Company Announces Its Board of Directors Approved a Dividend of Dream Bowl I Meme Coin Tokens to Holders of Common Stock and other Eligible Equity Securities with a Record Date of April 30, 2026 https://ml.globenewswire.com/media/e2f985bf-0880-4d05-8838-90a69c888cf9/small/logo-jpg.jpg https://www.hawaiihealthdigest.com/article/906946413-gh-research-welcomes-white-house-executive-order-to-accelerate-medical-treatments-for-serious-mental-illness Hawaii Health Digest en PressRelease 2026-04-20T13:00:00+00:00 GH Research Welcomes White House Executive Order to Accelerate Medical Treatments for Serious Mental Illness https://ml.globenewswire.com/media/a1baa9e5-3408-4f8f-b4aa-7c4204e0971b/small/full-colour-png.png https://www.hawaiihealthdigest.com/article/906946565-oragenics-reports-8-study-drug-doses-in-phase-iia-clinical-trial-of-onp-002-for-mild-traumatic-brain-injury Hawaii Health Digest en PressRelease 2026-04-20T13:00:00+00:00 Oragenics Reports 8 study drug doses in Phase IIa Clinical Trial of ONP-002 for Mild Traumatic Brain Injury https://ml.globenewswire.com/media/8b2c9d06-f009-4a6e-a465-8a1fe9640993/small/logo-jpg.jpg https://www.hawaiihealthdigest.com/article/906946797-avicanna-announces-agenda-for-6th-annual-clinical-symposium-on-cannabinoid-therapeutics Hawaii Health Digest en PressRelease 2026-04-20T13:00:00+00:00 Avicanna Announces Agenda for 6th Annual Clinical Symposium on Cannabinoid Therapeutics https://ml.globenewswire.com/media/dff23be4-6d2a-4fbc-a561-e13c2438d17a/medium/avicanna-announces-agenda-for-6th-annual-clinical-symposium.png https://www.hawaiihealthdigest.com/article/906946773-29-6-bn-life-sciences-consulting-services-market-forecasts-to-2034-rising-drug-complexity-ai-big-data-adoption-demand-for-real-world-evidence Hawaii Health Digest en PressRelease 2026-04-20T12:59:16+00:00 $29.6+ BN Life Sciences Consulting Services Market Forecasts to 2034: Rising Drug Complexity, AI & Big Data Adoption, Demand for Real-World Evidence, and Biotech Expansion with Novel Therapies https://ml.globenewswire.com/media/1f4cf0ab-7d76-4136-a6dc-a5545f80f538/small/zion-market-research-jpg.jpg https://www.hawaiihealthdigest.com/article/906946257-omega-laboratories-to-host-educational-panels-and-present-cannabix-marijuana-breath-test-solution-at-the-2026-ndasa-conference-in-california Hawaii Health Digest en PressRelease 2026-04-20T12:45:00+00:00 Omega Laboratories to Host Educational Panels and Present Cannabix Marijuana Breath Test Solution at the 2026 NDASA Conference in California https://ml.globenewswire.com/media/c82e010e-984e-4788-b222-2539a90d3394/small/logo-full-color-symbol-blueslash-png.png https://www.hawaiihealthdigest.com/article/906941093-akari-therapeutics-reports-positive-preclinical-data-for-aktx-101-demonstrating-differentiated-cytotoxicity-for-first-in-class-trop2-adc-payload Hawaii Health Digest en PressRelease 2026-04-20T12:35:00+00:00 Akari Therapeutics Reports Positive Preclinical Data for AKTX-101 Demonstrating Differentiated Cytotoxicity for First-in-Class TROP2 ADC Payload Targeting RNA Splicing https://ml.globenewswire.com/media/8d978f50-07a9-40a3-be69-45f51ccd94d9/small/akari-logo-1-jpg.jpg https://www.hawaiihealthdigest.com/article/906941037-integra-lifesciences-to-host-first-quarter-2026-financial-results-conference-call-on-may-5-2026 Hawaii Health Digest en PressRelease 2026-04-20T12:32:00+00:00 Integra LifeSciences to Host First Quarter 2026 Financial Results Conference Call on May 5, 2026 https://ml.globenewswire.com/media/80d27f1a-2d8e-44f2-92e9-57e14db38652/small/integra-promotional-logos-integra-logo-full-color-process-1.png https://www.hawaiihealthdigest.com/article/906940983-allogene-therapeutics-showcases-momentum-with-clinical-and-platform-advancements-in-allogeneic-car-t-at-aacr-2026 Hawaii Health Digest en PressRelease 2026-04-20T12:30:00+00:00 Allogene Therapeutics Showcases Momentum with Clinical and Platform Advancements in Allogeneic CAR T at AACR 2026 https://ml.globenewswire.com/media/87e8712c-0741-409f-9942-c91b31e7c5e1/small/allogene-png.png https://www.hawaiihealthdigest.com/article/906941042-cytodyn-presents-new-leronlimab-data-in-metastatic-triple-negative-breast-cancer-at-aacr-annual-meeting-2026 Hawaii Health Digest en PressRelease 2026-04-20T12:30:00+00:00 CytoDyn Presents New Leronlimab Data in Metastatic Triple-Negative Breast Cancer at AACR Annual Meeting 2026 https://ml.globenewswire.com/media/3b426b4d-6299-4c23-9f95-058174a5b7be/small/new-logo-png.png https://www.hawaiihealthdigest.com/article/906941088-envue-medical-announces-40th-u-s-hospital-customer-with-addition-of-a-virginia-medical-center-affiliated-with-the-mayo-clinic-care-network Hawaii Health Digest en PressRelease 2026-04-20T12:30:00+00:00 ENvue Medical Announces 40th U.S. Hospital Customer with Addition of a Virginia Medical Center Affiliated with the Mayo Clinic Care Network https://ml.globenewswire.com/media/e0a97028-a7c3-4dd6-a13f-a55e43617883/small/logo-small-722-jpg.jpg https://www.hawaiihealthdigest.com/article/906941213-when-science-becomes-an-asset-how-advancing-drug-pipelines-are-driving-real-time-valuation-in-biotech Hawaii Health Digest en PressRelease 2026-04-20T12:30:00+00:00 When Science Becomes an Asset: How Advancing Drug Pipelines Are Driving Real-Time Valuation in Biotech https://ml.globenewswire.com/media/920a567d-2571-4a09-a6f6-bcc7f1c26bd7/small/biomedwire-full-png.png https://www.hawaiihealthdigest.com/article/906941032-pharmala-biotech-positioned-to-supply-u-s-expanded-access-pathway-for-mdma-established-by-presidential-executive-order Hawaii Health Digest en PressRelease 2026-04-20T12:15:00+00:00 PharmAla Biotech Positioned to Supply U.S. Expanded Access Pathway for MDMA Established by Presidential Executive Order https://ml.globenewswire.com/media/20158980-8674-43e3-a0be-a10dca42410d/small/pharmala-biotech-logo-800-x-422-png.png https://www.hawaiihealthdigest.com/article/906941539-helus-pharma-expresses-support-for-executive-order-advancing-psychedelic-research-and-regulatory-pathways-for-serious-mental-health-conditions Hawaii Health Digest en PressRelease 2026-04-20T12:15:00+00:00 Helus Pharma Expresses Support for Executive Order Advancing Psychedelic Research and Regulatory Pathways for Serious Mental Health Conditions https://ml.globenewswire.com/media/575a4e81-a546-4d83-a092-e8f0df765900/small/hp-pms-with-margins-png.png https://www.hawaiihealthdigest.com/article/906940974-nanox-signs-commercial-agreement-with-howard-technology-solutions-to-deploy-300-nanox-arc-systems-across-u-s-over-three-years Hawaii Health Digest en PressRelease 2026-04-20T12:10:00+00:00 Nanox Signs Commercial Agreement with Howard Technology Solutions to Deploy 300 Nanox.ARC Systems Across U.S. Over Three Years https://ml-eu.globenewswire.com/media/7a1764f8-84e3-4b28-ae23-9add5d57c378/small/nanox-logo-4-png.png https://www.hawaiihealthdigest.com/article/906936633-boehringer-ingelheim-expands-investment-in-computational-innovation-with-new-ai-accelerator-in-uk-s-knowledge-quarter Hawaii Health Digest en PressRelease 2026-04-20T12:00:00+00:00 Boehringer Ingelheim expands investment in computational innovation with new AI Accelerator in UK’s Knowledge Quarter https://ml-eu.globenewswire.com/media/23506caa-2f73-498b-b15b-df82c00b9b21/medium/lord-patrick-vallance-and-steve-bates-obe-with-boehringer-re.jpg https://www.hawaiihealthdigest.com/article/906936706-amneal-announces-additional-positive-interim-phase-4-elevate-pd-results-with-crexont-for-parkinson-s-disease-including-over-3-more-hours-of-daily Hawaii Health Digest en PressRelease 2026-04-20T12:00:00+00:00 Amneal Announces Additional Positive Interim Phase 4 ELEVATE-PD Results with CREXONT® for Parkinson’s Disease, Including Over 3 More Hours of Daily “Good On” Time When Switching from RYTARY® https://ml.globenewswire.com/media/a20d6f40-90af-422f-ab14-47208fdbad2f/small/amneal-rgb-k-png.png https://www.hawaiihealthdigest.com/article/906936761-fulcrum-therapeutics-to-host-first-quarter-2026-financial-results-conference-call-and-webcast-on-monday-april-27-2026-at-8-00-a-m-et Hawaii Health Digest en PressRelease 2026-04-20T12:00:00+00:00 Fulcrum Therapeutics to Host First Quarter 2026 Financial Results Conference Call and Webcast on Monday, April 27, 2026, at 8:00 a.m. ET https://ml.globenewswire.com/media/3434fc83-4bcf-4d3c-ae26-23e5b1fd4252/small/fulcrum-logo-primary-full-color-rgb-large-png.png https://www.hawaiihealthdigest.com/article/906936994-ascendis-pharma-announces-commencement-of-trading-of-its-ordinary-shares-on-nasdaq Hawaii Health Digest en PressRelease 2026-04-20T12:00:00+00:00 Ascendis Pharma Announces Commencement of Trading of its Ordinary Shares on Nasdaq https://ml.globenewswire.com/media/b4b7c29a-478e-4a8e-b23b-b6a1cb18aee8/small/ascendis-final-logo-7-23-15-png.png https://www.hawaiihealthdigest.com/article/906937040-cosciens-biopharma-inc-provides-update-on-its-plan-to-suspend-u-s-public-company-reporting-obligations Hawaii Health Digest en PressRelease 2026-04-20T12:00:00+00:00 COSCIENS Biopharma Inc. Provides Update on its Plan to Suspend U.S. Public Company Reporting Obligations https://ml.globenewswire.com/media/703faafa-78e2-4d67-be2a-457eb4f57340/small/picture2-png.png https://www.hawaiihealthdigest.com/article/906937054-beyond-cancer-reports-updated-survival-and-safety-data-from-phase-1-uno-trial-presented-at-aacr-2026 Hawaii Health Digest en PressRelease 2026-04-20T12:00:00+00:00 Beyond Cancer Reports Updated Survival and Safety Data from Phase 1 UNO Trial Presented at AACR 2026 https://ml.globenewswire.com/media/c7ae3957-2763-4e5c-9594-57e1ba60ed59/small/beyond-air-the-magic-of-breathing-png.png https://www.hawaiihealthdigest.com/article/906937059-max-immunity-clinic-opens-in-markham-offering-regenerative-and-recovery-based-therapies Hawaii Health Digest en PressRelease 2026-04-20T12:00:00+00:00 Max Immunity Clinic Opens in Markham, Offering Regenerative and Recovery-Based Therapies https://ml.globenewswire.com/Resource/Download/74616897-d71c-4463-8157-1c6d9219fd1a/image1.png https://www.hawaiihealthdigest.com/article/906937079-atsena-therapeutics-receives-data-monitoring-committee-recommendation-to-proceed-with-pivotal-part-c-cohort-of-phase-1-2-3-lighthouse-trial-evaluating Hawaii Health Digest en PressRelease 2026-04-20T12:00:00+00:00 Atsena Therapeutics Receives Data Monitoring Committee Recommendation to Proceed with Pivotal Part C Cohort of Phase 1/2/3 LIGHTHOUSE Trial Evaluating ATSN-201 in Patients with X-linked Retinoschisis https://ml.globenewswire.com/media/90d0bd84-4404-435c-9875-3473b4cc7172/small/atsena-logo-jpg.jpg https://www.hawaiihealthdigest.com/article/906937089-kyverna-presents-longer-term-phase-2-data-for-miv-cel-in-generalized-myasthenia-gravis-at-aan-demonstrating-deep-durable-responses-through-52-weeks Hawaii Health Digest en PressRelease 2026-04-20T12:00:00+00:00 Kyverna Presents Longer-Term Phase 2 Data for Miv-cel in Generalized Myasthenia Gravis at AAN, Demonstrating Deep, Durable Responses through 52 Weeks https://ml.globenewswire.com/media/c166e9f5-941a-48b0-be17-c24d54785784/small/kyverna-primary-full-2-png.png https://www.hawaiihealthdigest.com/article/906937114-tenvie-therapeutics-announces-dosing-of-first-subject-in-phase-1-clinical-trial-of-tnv108-an-allosteric-sarm1-inhibitor Hawaii Health Digest en PressRelease 2026-04-20T12:00:00+00:00 Tenvie Therapeutics Announces Dosing of First Subject in Phase 1 Clinical Trial of TNV108, an Allosteric SARM1 inhibitor https://ml.globenewswire.com/media/311d9377-979c-4384-9258-5b496e854edb/small/tenvie-logo-gradient-rgb-png.png https://www.hawaiihealthdigest.com/article/906937116-bvi-gibt-bekannt-dass-virtuoso-eine-neue-chirurgische-plattform-mit-doppelfunktion-die-ce-kennzeichnung-gem-eu-mdr-erhalten-hat Hawaii Health Digest en PressRelease 2026-04-20T12:00:00+00:00 BVI gibt bekannt, dass Virtuoso®, eine neue chirurgische Plattform mit Doppelfunktion, die CE-Kennzeichnung gemäß EU-MDR erhalten hat https://ml.globenewswire.com/media/0e7f0025-cd6d-4b42-9d31-9d16f1b74c40/small/bvi-logo-png.png https://www.hawaiihealthdigest.com/article/906937117-lenz-therapeutics-announces-submission-of-marketing-authorization-application-to-the-medicines-and-healthcare-products-regulatory-agency-for-vizz-for Hawaii Health Digest en PressRelease 2026-04-20T12:00:00+00:00 LENZ Therapeutics Announces Submission of Marketing Authorization Application to the Medicines and Healthcare products Regulatory Agency for VIZZ® for the Treatment of Presbyopia in the United Kingdom https://ml.globenewswire.com/media/e058841a-d17f-4fd7-b817-0b2c8e6cb656/small/lenz-png.png https://www.hawaiihealthdigest.com/article/906937119-bvi-annonce-l-obtention-du-marquage-ce-au-titre-du-r-glement-europ-en-sur-les-dispositifs-m-dicaux-pour-virtuoso-une-toute-nouvelle-plateforme Hawaii Health Digest en PressRelease 2026-04-20T12:00:00+00:00 BVI annonce l’obtention du marquage CE au titre du Règlement européen sur les dispositifs médicaux pour Virtuoso®, une toute nouvelle plateforme chirurgicale à double fonction https://ml.globenewswire.com/media/0e7f0025-cd6d-4b42-9d31-9d16f1b74c40/small/bvi-logo-png.png https://www.hawaiihealthdigest.com/article/906937121-calidi-biotherapeutics-presents-new-data-on-its-differentiated-approach-to-in-situ-t-cell-engagers-including-a-new-candidate-targeting-trop-2-at-the Hawaii Health Digest en PressRelease 2026-04-20T12:00:00+00:00 Calidi Biotherapeutics Presents New Data on Its Differentiated Approach to In Situ T-Cell Engagers Including a New Candidate Targeting TROP-2 at the AACR Annual Meeting in April 2026 https://ml.globenewswire.com/media/9e574b79-be62-4805-a4b4-cb0b7dcc5fbd/small/calidibiotherapeutics-logo-2x-jpg.jpg https://www.hawaiihealthdigest.com/article/906937126-biocardia-and-japan-pmda-align-on-acceptability-of-cardiamp-clinical-data-to-support-regulatory-approval-in-ischemic-heart-failure Hawaii Health Digest en PressRelease 2026-04-20T12:00:00+00:00 BioCardia and Japan PMDA Align on Acceptability of CardiAMP Clinical Data to Support Regulatory Approval in Ischemic Heart Failure https://ml.globenewswire.com/media/4641bb53-4913-4654-a337-79383a5c7ab9/small/biocardia-final-logo-2016-jpeg-jpg.jpg https://www.hawaiihealthdigest.com/article/906937129-ardelyx-appoints-biopharmaceutical-veteran-felecia-w-ettenberg-as-chief-legal-officer Hawaii Health Digest en PressRelease 2026-04-20T12:00:00+00:00 Ardelyx Appoints Biopharmaceutical Veteran, Felecia W. Ettenberg, as Chief Legal Officer https://ml.globenewswire.com/media/cee4ae6d-7a85-44bf-9c02-87e7fa934ec2/small/ardelyx-logo-rgb-jpg.jpg https://www.hawaiihealthdigest.com/article/906937133-standard-dental-labs-inc-appoints-brendan-cummins-to-board-of-directors Hawaii Health Digest en PressRelease 2026-04-20T12:00:00+00:00 Standard Dental Labs Inc. Appoints Brendan Cummins to Board of Directors https://ml.globenewswire.com/media/2369a47c-d78d-419f-acb4-14fafec588aa/small/sdl-logo-2023-02-png.png https://www.hawaiihealthdigest.com/article/906937134-phathom-pharmaceuticals-to-report-first-quarter-2026-financial-results-and-provide-business-update-on-thursday-april-30-2026 Hawaii Health Digest en PressRelease 2026-04-20T12:00:00+00:00 Phathom Pharmaceuticals to Report First Quarter 2026 Financial Results and Provide Business Update on Thursday, April 30, 2026 https://ml.globenewswire.com/media/0baa6f51-c6cb-4b21-a4e0-573a18b8171c/small/phathom-pharm-logo-jpg.jpg https://www.hawaiihealthdigest.com/article/906937170-nanox-announces-fourth-quarter-of-2025-financial-results-and-provides-business-updates Hawaii Health Digest en PressRelease 2026-04-20T12:00:00+00:00 Nanox Announces Fourth Quarter of 2025 Financial Results and Provides Business Updates https://ml.globenewswire.com/media/57c1ffd6-84b3-46b9-b9b3-76666e6ba5a2/small/nano-logo-002-jpg.jpg https://www.hawaiihealthdigest.com/article/906937172-axe-compute-unveils-compute-reserve-dashboard-giving-investors-a-unified-view-of-its-nasdaq-stock-and-operational-strategic-compute-reserve Hawaii Health Digest en PressRelease 2026-04-20T12:00:00+00:00 Axe Compute Unveils Compute Reserve Dashboard, Giving Investors a Unified View of Its NASDAQ Stock and Operational Strategic Compute Reserve https://ml.globenewswire.com/media/0722059f-4d31-435e-974f-ff669a2cb2e4/small/axe-compute.png https://www.hawaiihealthdigest.com/article/906937184-askbio-s-viralgen-to-supply-commercial-scale-drug-product-for-regenerate-pd-investigational-gene-therapy-phase-ii-trial-for-parkinson-s-disease Hawaii Health Digest en PressRelease 2026-04-20T12:00:00+00:00 AskBio's Viralgen to Supply Commercial-Scale Drug Product for REGENERATE-PD Investigational Gene Therapy Phase II Trial for Parkinson’s Disease https://ml.globenewswire.com/media/MTk3Y2I1OTYtYWYwYy00MDFmLWFlNTctYTVhZjUyODU0NTNlLTEyODY3MTItMjAyNi0wNC0yMC1lbg==/tiny/Asklepios-BioPharmaceutical-In.png https://www.hawaiihealthdigest.com/article/906937392-helus-pharma-announces-chief-executive-officer-transition-eric-so-to-resume-role-as-interim-chief-executive-officer Hawaii Health Digest en PressRelease 2026-04-20T12:00:00+00:00 Helus Pharma Announces Chief Executive Officer Transition; Eric So to Resume Role as Interim Chief Executive Officer https://ml.globenewswire.com/media/575a4e81-a546-4d83-a092-e8f0df765900/small/hp-pms-with-margins-png.png https://www.hawaiihealthdigest.com/article/906937214-artelo-announces-peer-reviewed-publication-supporting-its-fabp5-inhibitor-art26-12-as-a-novel-pain-treatment-with-a-potentially-first-in-class-profile Hawaii Health Digest en PressRelease 2026-04-20T11:50:00+00:00 Artelo Announces Peer-Reviewed Publication Supporting its FABP5 Inhibitor ART26.12 as a Novel Pain Treatment with a Potentially First-in-Class Profile https://ml.globenewswire.com/media/460502d7-b0d3-43d8-a15a-5b2bb963bbbb/small/artelo-jpg.jpg